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1. Abstract 
The regulation of gene expression during the development of organisms is an 
essential process. MicroRNAs (miRNAs) are small non-coding RNA molecules and 
post-transcriptional regulators of gene expression. It is believed that miRNAs 
regulate a large set of transcripts in the cell and that malfunctions in miRNA 
expression cause diseases. Generally, miRNAs repress translation and/or lead to 
degradation of their target mRNA. At present, the mechanism of miRNA-mediated 
gene silencing is poorly understood. The identification of novel miRNA target mRNAs 
could help in understanding the underlying mechanisms and contribute to the global 
picture of miRNA-mediated gene regulation. In this study I aimed to identify novel 
miRNA targets repressed at the translation level in Drosophila S2 cells by doing 
polysome analysis. 
First, I demonstrated the migration of potentially repressed endogenous miRNA 
targets and repressed Firefly luciferase sensors in polysomal fractions. These 
experiments suggest that the distribution of miRNA targets does not necessarily 
reflect their translational status. Therefore the identification of novel miRNA targets 
using polysome analysis was not feasible. 
Since the finding of repressed miRNA targets in polysome fractions was somewhat 
surprising, I analyzed the distribution of miRNA effector components and the mRNA 
degradation machinery in polysome profiles and ribosome pelleting experiments. The 
miRNA effector component AGO1 and the decapping activator HPat consistently co-
purify with ribosomes very well while other factors such as GW182 and CCR4 co-
purify only to a smaller extent.  
In summary miRNA targets, miRNAs as well as factors of the miRNA and mRNA 
degradation machinery co-migrate with polyribosomes in Drosophila S2 cells. 
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2. Zusammenfassung 
Die Regulierung der Genexpression während der Entwicklung von Organismen ist 
ein essentieller Prozess. MicroRNAs (miRNAs) sind kleine nicht-codierende RNA 
Moleküle die die Genexpression nach der Transkription regulieren. Man schätzt, 
dass miRNAs eine große Anzahl der mRNAs in der Zelle regulieren und, dass 
Defekte in der miRNA Expression zu Krankheiten führen können. Generell hemmen 
miRNAs die Translation und/oder führen zum Abbau ihrer Ziel-mRNA. Gegenwärtig 
ist der Mechanismus der durch miRNAs induzierten Genhemmung noch nicht 
vollständig geklärt. Die Identifizierung von neuen Ziel-mRNAs von miRNAs könnte 
dabei helfen diese Mechanismen zu verstehen und gleichzeitig zum globalen Bild der 
miRNA-induzierten Genregulation beitragen. Mit dieser Untersuchung beabsichtigte 
ich die Identifizierung neuer Ziel-mRNAs welche auf Translationsebene gehemmt 
werden in Drosophila S2 Zellen durch Polysome Analyse.  
Als erstes konnte ich zeigen, dass potentielle endogene Ziel-mRNAs von miRNAs 
und reprimierte Firefly luziferase Sensoren in den Polysom-Fraktionen migrieren. 
Diese Experimente weisen darauf hin, dass die Verteilung von reprimierten Ziel-
mRNAs nicht notwendigerweise deren Translationsstatus wiedergibt. Daher war die 
Identifizierung von neuen Ziel-mRNAs von miRNAs durch Polysome Analyse nicht 
durchführbar. 
Da es etwas überraschend war, reprimierte mRNAs in Polysome-Fraktionen zu 
finden, analysierte ich in der Folge die Verteilung von miRNA Effektor Komponenten 
und Faktoren der mRNA Abbaumaschinerie in Polysom Gradienten und 
Ribosomenpelletierungs-Experimenten. Das miRNA Effektorprotein AGO1 und der 
„Decapping“ Aktivator HPat migrierten konsistent mit den Ribosomen während 
Faktoren wie GW182 oder CCR4 in weit kleinerem Ausmaß mit den Ribosomen 
migrierten.  
Zusammengefasst bedeutet das, dass Ziel-mRNAs von miRNAs, miRNAs selber und 
Faktoren der miRNA und mRNA Degradierungsmaschinerie in Drosophila S2 Zellen 
mit den Ribosomen migrieren. 
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3. Introduction 
How can cells with an identical genome fulfill totally different functions and form a 
complex system such as an animal or a human being? One answer to this question is 
that not all genes of an organism are expressed at the same time. The development 
of organisms is controlled by processes which regulate gene expression. Gene 
regulation in eukaryotes includes all the processes by which nuclear, cytoplasmic or 
intercellular factors influence the induction or repression of a gene at the 
transcriptional or translational level (bibliography links: MeSH). For example, genes 
can be regulated by chemical modifications of DNA or histone proteins resulting in 
activation or repression of the transcription of genes (Allis, 2007). Regulation at the 
transcriptional level can be mediated by a whole range of different transcription 
factors or enhancer sites in the DNA. After transcription the transcripts are subject to 
regulation by mechanisms such as splicing, modulation of the transcript ends, mRNA 
export or the binding of regulatory proteins to their target mRNAs (reviewed in 
Wilhelm, 2005). One mechanisms of posttranscriptional gene regulation is mediated 
by microRNAs which cause translation repression and/or degradation of target 
transcripts (reviewed in Fabian, 2010).  
 
3.1. microRNAs 
The first microRNAs (miRNAs) in animals were discovered in 1993 in C.elegans by 
Lee and Co-workers (Lee, 1993). Over the years miRNAs were found to be important 
regulators of gene expression in protozoa, plants and animals. miRNAs repress their 
target mRNAs by inhibiting protein translation and/or mRNA degradation (reviewed in 
Fabian, 2010). miRNAs are involved in the regulation of biological processes like cell 
growth, metabolism and development (reviewed in Chen, 2005 and Ivey, 2010). Due 
to their importance in gene regulation, it is not surprising that malfunctions in the 
miRNA mediated regulation have been linked to cancer (reviewed in Croce, 2009) or 
chronic inflammatory diseases (reviewed in Kanwar, 2010). miRNAs are about 21 
nucleotides long and belong to the class of small non-coding RNAs. 
  Introduction 
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3.2. Biogenesis of microRNAs 
Generally, miRNAs are transcribed by the RNA polymerase II mostly from miRNA 
genes or introns of protein-coding transcripts (Cai et al 2004; Rodriguez et al 2004). 
The transcripts fold into dsRNA-like hairpin precursor molecules, the so called pri-
microRNAs (Lee, 2002). pri-miRNAs are processed in two steps, which are catalyzed 
by the RNase III type enzymes, Drosha and Dicer (Lee, 2003). Drosha acts in the 
nucleus and requires partner proteins: Pasha in D. melanogaster or DGCR8 in 
mammals. The Drosha/DGCR8 (or pasha) complex processes the pri-miRNAs into 
~70 nucleotide long hairpins called pre-miRNAs (Lee, 2002; Denli, 2004; Han, 2004). 
Then the pre-miRNAs are transported into the cytoplasm by exportin-5 which 
recognizes specifically the end structure of pre-miRNAs. The transport is mediated by 
a Ran-GTP dependant mechanism (Yi, 
2003). In the cytoplasm pre-miRNAs are 
cleaved by Dicer, which acts in a 
complex with Loquacious in Drosophila or 
TRBP in mammals. This is the final 
processing step which results in ~21 
nucleotide long miRNA duplexes 
(Bernstein, 2001; Chendrimada, 2005; 
Forstemann, 2005). One strand of the 
duplex, the mature miRNA, is 
incorporated into ribonucleoprotein 
complexes called miRNPs or RNA-
induced silencing complex (miRISC) 
(Hammond, 2000). The loaded miRISC is 
delivered to its target mRNA and causes 
translational repression and/or mRNA 
degradation. 
 
Figure 3.1.: Biogenesis of microRNAs (Chen, 2005) 
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3.3. Target recognition by miRNAs 
The interaction of miRNAs with their mRNA targets is mediated by base-pairing. As 
shown by bioinformatic predictions and experimental characterizations, the binding 
sites for miRNAs on their mRNA targets predominantly lie in the 3‟ untranslated 
region (3‟UTR) (Lai, 2002; Reinhart, 2000; ). The miRNA: target mRNA base-pairing 
follows a set of general rules (figure 3.2.). 
 
Figure 3.2.: Principles of miRNA-mRNA interactions (Filipowicz, 2008) 
 
First, in animal cells it is important for the miRNA:mRNA interaction that the miRNA 5‟ 
nucleotides 2-8, the so-called seed-region, base-pair with perfect complementary to 
their target mRNA (Doench, 2004; Brennecke, 2005). The repression of the target is 
enhanced when an adenosine is present opposite of the miRNA base 1 and an 
adenosine or uridine is present opposite miRNA base 9 (Nielson, 2007). Secondly, 
the central region of the miRNAs base-paired with their target mRNAs contains 
mismatches and bulges (Reinhart, 2000; Kiriakidou, 2004). This general feature is a 
major difference to another small-RNA-mediated silencing mechanisms (siRNA 
silencing) were endonucleolytic cleavage of the mRNA target is mediated through 
perfect complementarity of siRNA and target. Furthermore, in several cases the 3‟ 
half of the miRNA is also partially complementary to the target and thereby stabilizes 
the miRNA:mRNA interaction (Brennecke, 2005). That becomes of particular 
importance when the base-pairing with the seed-region is not optimal (Brennecke, 
2005; Grimson, 2007). The efficiacy of the binding site can be improved by features 
such as an AU-rich nucleotide composition near the site or positioning around 15 
nucleotides from the stop codon (Grimson, 2007).  
It should be considered though, that the rules for target recognition mentioned here 
do not apply for all miRNA-mRNA interactions. For example, some animal miRNAs 
target the 5‟UTR of mRNAs, what even appeared to result in an activation of 
translation rather than in a repression (Orom, 2008). Further exceptions have been 
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found showing that perfect seed-pairing is not always required for a functional 
miRNA:target interactions (Didiano, 2006 and 2008; Nahvi, 2009). Nevertheless, the 
above mentioned general principles seem to apply for most interactions.  
 
3.4. miRNA-mediated gene repression 
In order to function miRNAs are loaded into the RISC (miRISC) complex. The key 
components of the miRISC are Argonaute and GW182 proteins. The miRISC binds to 
its target transcript and affects translation by unknown mechanisms. The literature 
suggests several mechanisms by which miRNAs can lead to translational repression 
and/or degradation. Before I describe these mechanisms, I will give a brief 
introduction into translation and decay mechanisms in eukaryotes. 
 
3.4.1. Eukaryotic Translation 
The process of mRNA translation in eukaryotes can be divided into three major 
steps: initiation, elongation and termination. 
 
3.4.1.1 Initiation 
The start of translation (initiation) is the most complex step and therefore a common 
target for translational control in eukaryotes (reviewed in Kapp, 2004). There are two 
different mechanisms: one is dependent on the 5‟cap mRNA structure while in the 
other one translation is initiated independently from the cap structure.  
 
Cap-dependent translation initiation 
The majority of the mRNAs in a eukaryotic cell are translated by a cap-dependent 
mechanism (reviewed in Jackson,2010). The cap structure is a 7-methylguanosine 
(m7G) at the 5‟ terminus of most eukaryotic mRNAs which are transcribed by 
Polymerase II in the nucleus. The cap structure is important for the stability of the 
mRNA and for translation initiation.  
The initial step of translation initiation is the recognition of the mRNA which is 
mediated by the 5‟cap of the mRNA. The whole initiation process requires at least 9 
different eukaryotic initiation factors (eIFs) (reviewed in Jackson, 2010). First, the 
ternary complex which comprises of eIF2- GTP-Met-tRNA binds to the small 
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ribosomal (40S) subunit (reviewed in Kapp, 2004). Very important for the process is 
the el4F complex (figure 3.3.) which is composed of three subunits: eIF4A, eIF4E and 
eIF4G (Edery, 1983; Grifo, 1983). elF4A is an ATP-dependent RNA helicase that is 
thought to unwind the mRNA 5‟UTR and elF4E binds the 5‟cap structure. eIF4G acts 
as a scaffolding protein and interacts with eIF4A and the multi-subunit initiation factor 
eIF3. So, the 40S ribosomal subunit is recruited and forms the 43S complex with the 
initiation factors. Upon loading, the 43S complex scans along the mRNA in 5‟3‟ 
direction until it encounters an AUG startcodon. This is followed by the joining of the 
60S ribosomal subunit and results in the formation of a functional 80S ribosome on 
the mRNA. eIF6 can prevent the association of the 60S subunit by binding to it 
(reviewed by Jackson, 2010; Kapp, 2004). Another important factor in ribosome 
recruitment is the Poly(A) tail, a homopolymeric stretch of 25-250 adenine 
nucleotides at the 3‟end of most eukaryotic mRNAs. The poly(A) tail prevents mRNA 
degradation and acts as translational enhancer (bibliography links : scitable nature). 
Important for the latter function are the poly(A)-binding proteins (PABP), which 
interact with elF4G. As a 
consequence the circularization of 
the mRNA is promoted and that 
stabilizes the interaction of elF4E 
with the 5‟cap structure and possibly 
facilitates ribosome recycling (Wells, 
1998; Derry, 2006). mRNA 
circularization is thought to enhance 
the rate of initiated translation 
rounds. This mechanism also 
ensures that partially degraded 
mRNA (which has lost is 3‟end) will 
not be efficiently translated anymore 
(reviewed by Kapp, 2004). 
 
Figure 3.3.: Initiation of cap-dependant translation (Filipowicz, 2008) 
Red circle….5‟cap structure  
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Cap-independent translation 
Internal ribosome entry sites (IRES) have been discovered initially in mRNAs of 
picornaviruses (Jang, 1988) and provide an alternative mechanism of translational 
initiation. An IRES is an element in the 5‟UTR of mRNAs that allows an association of 
ribosomes with the mRNA independently of a 5‟ cap structure and thereby initiates 
translation (reviewed in Hellen, 2001). Viral IRESs use distinct mechanisms for 
translational initiation which are mainly based on interactions with eIFs and/or 40S 
ribosomal subunit (reviewed in Jackson, 2010). Mostly, the initiation does not require 
eIF4E, the cap-binding unit of the eIF4F complex (reviewed in Hellen, 2001). Over 
the years, IRES have been found in a multitude of cellular mRNAs (Pinkstaff, 2001; 
Fernandez, et al., 2001; Pozner, 2000;) and for some of them a physiological function 
could be demonstrated in yeast (Gilbert, 2007). 
 
3.4.1.3. Elongation  
After initiation of translation, the peptide elongation starts by adding amino-acids 
according to the codon sequence found in the mRNA. While the initial tRNA occupies 
the P site of the ribosome, an aminoacyl tRNA is loaded into the A site of the 
ribosome by a complex of elongation factors with GTP. Several mechanisms like 
codon-anticodon base-pairing ensure that only the cognate tRNA is selected. Upon 
tRNA selection, the peptidyl transferase catalyzes the formation of a peptide bond 
between the new amino acids and the growing peptide chain. Peptide bond formation 
is followed by translocation of the mRNA-tRNA complex by one codon (reviewed in 
Kapp, 2004). 
  
3.4.1.4. Termination 
The termination step occurs when a stop codon is encountered at the ribosomal A 
site. The polypeptide is released by hydrolysis of the ester bond linking the tRNA (at 
the P site) and the peptide. The ribosomal subunits dissociate. Several release 
factors play a role here and the peptidyl transferase is believed to catalyze the 
hydrolysis reaction (reviewed in Kapp, 2004). 
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3.4.2. mRNA decay mechanisms in eukaryotes 
There are two mRNA degradation pathways of bulk mRNAs in the cytoplasm in 
eukaryotes. Both are initiated by deadenylation followed either by degradation 
through the exosome (3‟5‟decay) or decapping and 5‟3‟ degradation. The 
miRISC can recruit the general 5‟3‟ decay machinery to its target mRNAs and 
accelerate their degradation (reviewed in Eulalio, 2007b). 
 
3.4.2.1. Deadenylation-dependent mRNA decay 
In order to degrade an mRNA their protective structures, the 5‟ 7-methylguanosine 
cap and the 3‟ Poly(A) tail have to be removed. The decay of most eukaryotic 
mRNAs is initiated by shortening of the poly(A) tail, the so called deadenylation 
(figure 3.4.). The enzymes responsible for the poly(A) tail removal are termed 
deadenylases. Among the characterized deadenylases in eukaryotes are PAN2-
PAN3, PARN and the most prominent one, CCR4-NOT (reviewed by Garneau, 
2007). The CCR4-NOT complex consists of nine proteins and its activity is inhibited 
by Poly(A)-binding proteins (PABP) (Tucker, 2002). The deadenylation step is 
reversible – mRNAs can be adenylated and return to active translation. However, if 
deadenylation is not reversed, the decay process proceeds in two alternative routes 
(reviewed in Garneau, 2007). 
  Introduction 
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Figure 3.4.: Deadenylation-dependant mRNA degradation in eukaryotes 
The 3‟poly(A) tail of the mRNA is removed by a deadenylase complex (CCR4-NOT or 
PARN). Afterwards the mRNA can be degraded by two mechanisms: the 5‟3‟ or the 3‟5‟ 
decay. In the 5‟3‟ degradation, the Lsm1-7 complex associates with the 3‟end of the mRNA 
and facilitates the recruitment of the decapping complex. After decapping the mRNA is 
degraded by the exoribonuclease XRN1. 
In the 3‟5‟ decay the exosome starts degrading the mRNA from the 3‟end. The 5‟cap 
remains and is degraded by the scavenger-decapping enzyme DcpS. 
 
3’ 5’ mRNA decay 
In this mRNA decay pathway, the deadenylated 3‟end of the mRNA is directly 
degraded by the exosome (figure 3.4.). The exosome is a 10-12 subunit complex that 
consist of 6 proteins similar to 3‟5‟ phosphorolytic exoribonucleases and some 
accessory proteins. It is not known whether all subunits are catalytically active or 
which ones are responsible for target recognition (reviewed by Garneau, 2007). The 
oligomer containing the 5‟cap is metabolized by the scavenger decapping enzyme 
DcpS (Liu, 2002). 
 
5’  3’ decay 
This is the major mRNA degradation route of bulk mRNA in eukaryotes. 
Deadenylation is followed by the removal of the 5‟cap structure in a process called 
decapping (figure 3.4.). The decapping complex consists of decapping enzyme DCP2 
and enhancers of decapping. In Drosophila these decapping enhancers (or 
activators) are Ge-1, HPat, Me31B and EDC3 (Yu, 2005; Bonnerot, 2000; 
Kshirsagar, 2004; Schwartz, 2003). Furthermore, accessory proteins such as the 
(adapted from 
Garneau, 2007) 
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Lsm1-7 complex also play a role in decapping (Tharun, 2001; Coller, 2001). 
However, HPat and Me31B have also a role in mediating translational repression 
(Coller, 2005; Parker 2010). After decapping, the mRNA is degraded in 5‟  3‟ 
direction by an exoribonuclease termed XRN1 (reviewed by Garneau, 2007). The 
5‟3‟ mRNA degradation machinery has been linked to miRNA-mediated repression. 
CCR4-NotI, DCP2 and enhancers of decapping are required for miRNA-mediated 
mRNA decay in Drosophila melanogaster cells (Behm-Ansmant, 2006; Eulalio 
2007a). 
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3.4.3. The mechanisms of miRNA mediated gene repression 
The mechanisms by which miRNAs inhibit protein synthesis are not fully understood. 
It is known that miRNAs can inhibit translation and/or accelerate deadenylation and 
degradation of their target mRNAs. The following section discusses the possible 
mechanisms by which miRNAs regulate mRNAs. 
 
(Filipowicz, 2008) 
Figure 3.5.:Suggested mechanisms for post-transcriptional gene repression by 
miRNAs 
Deadenylation: upon binding of loaded miRNPs (micro-Ribonucleoproteincomplexes) to the 
mRNA target, deadenylation is induced leading to the decay of the target mRNA. 
Initiation inhibition: miRNPs bound to the mRNA target repress the initiation of translation by 
either interfering with cap-recognition or ribosome assembly. 
The mRNAs repressed by these two mechanisms are suggested to be moved into special 
cytoplasmic foci, the P-bodies. 
Elongation inhibition: miRNPs repress translation at the elongation step of translation 
resulting in the drop-off of ribosomes and generally a slowed down translation process. 
Proteolysis: miRNPs repress translation by proteolytic cleavage of newly produced 
polypeptides. However, no protease has been identified.  
Red circle 5‟cap 
elF4E  eukaryotic translation initiation factor 
AAA  3‟poly(A)tail 
Grey circles ribosomes 
CCR4-NOT Deadenylase Complex 
ORF  open reading frame 
X  unknown protease 
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3.4.3.1. Initiation inhibition 
Several studies, indicate that miRNAs suppress mRNA translation at the initiation 
step. It is believed that the miRNP bound to its target mRNA, inhibits initiation of 
translation by interfering with the recognition of the 5‟cap structure or the assembly of 
the ribosome (figure 3.5.). The evidence for this theory is derived from polysome 
gradient experiments. For description of polysome analysis see: section 6, 
background of this study. Concerning miRNA mediated repression, studies were 
performed analyzing endogenous (Ding, 2009; Bhattacharyya, 2006) and reporter 
miRNA targets (Huang, 2007; Pillai, 2005) in polysome gradients. These studies 
found that upon repression miRNA targets are not migrating in polysome fractions 
but shifted to the lighter (RNP) fractions of a gradient. This indicates that ribosomes 
were not recruited to the repressed miRNA targets anymore. A report from Pillai and 
co-workers (Pillai, 2005) demonstrated further that cap-independent translation is not 
subjected to miRNA-mediated repression. This suggests that the miRISC might 
interfere with the cap-recognition process during translation initiation. Another study 
was performed in an in vitro system of D. melanogaster embryos. The study 
demonstrates that the miRNA miR2 inhibits translation only in the presence of the 
5‟cap structure suggesting again the miRNA interferes with the cap-recognition 
process during translational initiation. Interestingly, the study showed that when 
polysome formation is inhibited miR2 induces the formation of heavy mRNPs which 
sediment similarly to polysomes in a density gradient. These structures were termed 
pseudo-polysomes (Thermann, 2007; Moretti, 2010).  
In summary, there exist several evidences for miRNA repression at translational 
initiation from in culture and in vitro systems using endogenous and reporter miRNA 
targets. 
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3.4.3.2. Elongation inhibition 
This theory states that miRNPs repress translation during the elongation of the 
peptide chain. It has been suggested that miRNA repression results in the drop-off of 
ribosomes and thereby slows down the translation process (reviewed in Filipowicz, 
2008). The evidence for this theory is also mainly based on polysome gradient 
analyses: Repressed endogenous mRNAs from C.elegans (Olsen, 1999; Seggerson, 
2002) and HeLa cells (Maroney, 2006) were found in the polysomal fractions of 
density gradients. Similarly, studies performed with reporter miRNA targets in 
mammalian cells found that the reporters migrate with polysomes regardless of their 
repression state (Nottrott, 2006; Petersen, 2006). Furthermore, miRNAs and AGO 
proteins have been shown to co-migrate with polysomes as well (Nottrott, 2006; 
Maroney, 2006). However, so far there is no molecular mechanism known that could 
explain postinitiation repression (reviewed in Fabian, 2010). 
 
3.4.3.3. Proteolysis 
The proteolysis theory is an alternative hyphothesis to rationalize that repressed 
miRNA targets are migrating with polysomes. This model suggests that proteins may 
be continously synthesized from the repressed mRNAs but they do not accumulate 
since they become rapidly degraded by proteases. The miRNPs have the function to 
recruit proteases in this model (reviewed in Filipowicz, 2008). Several studies have 
been performed to adress the proteolysis theory. One study tried unsuccesfully to purify 
nascent polypeptides from a repressed reporter in immunoprecipitation experiments 
(Nottrott, 2006). Similarly, no nascent polypeptides from a repressed reporter could 
be detected in pulse-field experiments (Petersen, 2006). Moreover, no protease has 
been identified so far to mediate this process.  
Thus, there are no positive results at present which could support the proteolysis 
model. 
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3.4.3.4. mRNA degradation 
Several reports indicate that miRNA repression frequently causes acceleration of 
mRNA decay of their mRNA targets (Wu, 2006; Bagga, 2005; Giraldez, 2006). 
Enzymes involved in the 5‟3‟ degradation pathway have been demonstrated to be 
essential for miRNA mediated decay (reviewed in Eulalio, 2007b; Behm-Ansmant, 
2006).  
The general mechanism of miRNA mediated decay in animals starts with the binding 
of AGO1-GW182 complexes loaded with the respective miRNA to their mRNA target. 
Then the general 5‟3‟ decay pathway is initiated by deadenylation (see section 
3.4.2). The enzymes catalyzing that step form the CAF1-CCR4-NOT1 complex. After 
deadenylation, the 5‟cap of the mRNA is removed by the decapping protein DCP2. 
The decapping complex consists further of DCP1, enhancer of decapping 4 (EDC4) 
and the RNA helicase DEAD-box protein 6 (DDX6), which is homologous to 
Drosophila melanogaster Me31b. After deadenylation and subsequent decapping, 
the target mRNA is degraded by the exonuclease XRN1 in 5‟3‟ direction (reviewed 
in Garneau 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
(Tritschler, 2010) 
Figure 3.4.: Model of miRNA mediated silencing  
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3.5. A detailed description of main proteins involved in the 
miRNA-mediated silencing 
 
I want to describe three proteins involved in miRNA mediated silencing more in detail 
since they have been studied in this thesis: AGO1, GW182 and HPat. AGO1 and 
GW182 are the key components of the miRISC and HPat is a general decapping 
activator. 
 
3.5.1. Argonaute Proteins (AGO) 
Argonaute proteins are key components of the miRISC complex and essential for 
miRNA-mediated silencing. 
 
 
(Jinek & Doudna, 2009) 
Figure 3.5.: Domain organization of eukaryotic Argonaute proteins 
N-terminal, PAZ, MID and PIWI are the 4 domains of eukaryotic Argonaute proteins 
 
Within the family of the Argonaute proteins are several subfamilies which recognize 
different small RNA types and act in various small-RNA silencing pathways (reviewed 
in Jinek, 2009). The number of Argonaute proteins varies among different species. D. 
melanogaster has two Argonaute (AGO) proteins: AGO1 is thought to act 
predominantly in the miRNA silencing pathway and AGO2 in the RNA interference 
(RNAi) pathway (Okamura, 2004; Hammond, 2001). In humans there are 4 AGO 
proteins which all act in miRNA repression but only AGO2 has slicer acitvity 
(Landthaler, 2008; Liu, 2004). A common feature of eukaryotic AGO proteins is that 
they are multidomain proteins (figure 3.5.) harboring four domains: N-terminal, Piwi-
Argonaute-Zwilli (PAZ), middle (MID) and PIWI (Cerutti, 2000; Song, 2004). The PAZ 
domain can recognize 3‟-ends of ssRNAs (Lingel, 2004; Ma, 2004). As mentioned in 
section 3.2. during miRNA biogenesis the action of Drosha and Dicer generates 
miRNA duplexes with characteristic 3‟-overhangs. It has been suggested that the 
PAZ domain is involved in binding to these 3‟-overhangs (reviewed in Hutvagner, 
2008). The Mid domain of metazoan AGO proteins has a motif (MC domain) that has 
some homology to the 5‟cap binding motif of eIF4E. Some recent findings suggested 
that the Mid domain of AGO proteins (D.melanogaster AGO1) is allosterically 
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regulated by miRNAs (Djuranovic, 2010). It was demonstrated that there is a 
functional allostery between two distinct sites: one site which binds the miRNA: 
mRNA target duplex and the other site binding the 5‟cap structure of eukaryotic 
mRNAs. The authors claim that this could explain why the RISC does not lead to a 
repressive action on the target mediated by binding to the 5‟cap prior to full miRNA: 
target recognition (Djuranovic, 2010). 
In AGO proteins with „slicer activity‟, the PIWI domain adopts an RNase-H-like fold 
(Song, 2004). RNase-H-like enzymes cleave RNA using a DNA template. This 
catalysis requires an Asp-Asp-Glu/Asp/His/Lys motif in the catalytic center and the 
binding of two metal ions (reviewed by Tolia, 2007). However, the presence of a 
catalytic center in the PIWI domain of an AGO protein does not necessarily result in 
target mRNA cleavage. For instance, in D. melanogaster, both AGO1 and AGO2 
have complete Asp-Asp-His motifs and are capable of slicing. Nevertheless, AGO1 is 
a much less efficient enzyme than AGO2 because it releases products at a slower 
rate and therefore has a slower turnover (Förstemann, 2007). This suggests that 
other factors, in addition to the catalytic sites, determine if an AGO protein is an 
efficient slicer or not (reviewed in Jinek, 2009). 
The loading of the RISC with a miRNA takes place in a complex and requires the 5‟ 
phosphate groups and the 3‟ hydroxyl overhangs of the miRNA duplex. The RISC-
loading complex consists of AGO protein, Dicer and TRPB in human cells or 
Loquacious in D.melanogaster (Macrae, 2008; Saito, 2005). From the miRNA duplex, 
the strand with the less thermodynamically stable 5‟end, the so-called guide strand, 
is loaded into the RISC complex (Schwarz, 2003). The first nucleotide of the guide 
strand is unpaired and anchored via its 5‟terminal phosphate into the junction of the 
MID and PIWI domains (Ma, 2005). The 3‟ end of the miRNA guide strand was 
shown to be bound to the PAZ domain (Ma, 2004; Lingel, 2004). The nucleotides 2-6 
of the guide strand, the „seed region‟ contact AGO over their phosphate-ribose 
backbone. Thereby these nucleotides are displayed on the protein surface and are 
capable of binding to the mRNA target (Parker, 2005; Wang, 2008;). The mechanism 
of target-mRNA recognition has been studied in Thermus thermophilus. In order to 
bind the target mRNA, the seed region base-pairs to the target mRNA and AGO 
undergoes a pronounced conformational change into a more open conformation 
(Wang, 2008). Thereby the N-terminal and PAZ domains are rotated away from the 
lobe containing the MID and PIWI domains. As a consequence the target mRNA is 
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accomodated in the channel between MID and PIWI domain (Wang, 2008). The MID-
PIWI region of AGO1 has been found to interact directly with GW182 (Behm-
Ansmant, 2006; Till, 2007). 
 
3.5.2. GW182 
In animals, AGO proteins are not sufficient for silencing and require interaction with 
members of the GW182 family (Behm-Ansmant, 2006). GW182 proteins were 
identified as direct interaction partners of AGO proteins and found to be crucial for 
miRNA-mediated gene repression and degradation (Ding, 2005; Liu, 2005; Meister, 
2005; Rehwinkel, 2005). In vertebrates three GW182 paralogs exist while insects 
have only one (reviewed in Tritschler, 2010). The name GW182 is derived from the 
molecular weight of the protein and the presence of glycin and tryptophan (GW) 
repeats in its sequence. The protein consists of two characteristic structural domains 
(figure 3.6): an ubiquitin-associated domain (UBA) and a carboxy-terminal RNA 
recognition motif (RRM). Further the protein consists of some other regions which 
include the amino-terminal, the Mid, the C-terminal and a Glutamine (Q)-rich domain 
(Behm-Ansmant, 2006; reviewed in Tritschler, 2010). The N- and C-terminal and the 
Mid region contain different amounts of GW repeats.  
 
 
 
(adapted from Tritschler, 2010) 
Figure 3.6.: Domain organization of GW182 from Drosophila melanogaster 
The GW domain contains glycin- tryptophan repeats and is binding to AGO1. The silencing 
domain comprises of M1, M2, the poly(A)-binding protein interacting motif 2 (PAM2) and the 
carboxy-terminal domain (C-term). Furthermore there is an ubiquitin-associated domain 
(UBA), an RNA-recognition motif (RRM) and a glutamine (Q)-rich region. 
 
The N-terminal GW182 domain is necessary and sufficient for GW182 – AGO1 
interaction (Behm-Ansmant, 2006). This region has the highest amount of GW-
repeats which were shown to act as AGO-binding determinants (Till, 2007; El-Shami, 
2007). The Mid and C-terminal regions make up the so called „silencing domain‟ 
  Introduction 
   23 
(figure 3.6.). It was demonstrated that this silencing domain is essential for 
translational repression and degradation of miRNA targets in D.melanogaster 
(Chekulaeva, 2010). The Mid and C-terminal domains act independently from AGO-
binding or P body localization. It has been shown that depletion of GW182 
suppresses miRNA mediated silencing and that tethering GW182 to a reporter 
mRNA induces translational repression also in the absence of AGO proteins (Behm-
Ansmant, 2006; Lazzaretti, 2009). Therefore this region was suggested to have 
autonomous silencing activity (Eulalio, 2009a; Zipprich, 2009). Interestingly, the 
silencing domain of GW182 has been found to interact with the cytoplasmic poly(A)-
binding protein 1 (PABPC1) in D. melanogaster, human and mammalian cells (Zekri, 
2009; reviewed in Jinek, 2010 and Fabian, 2009). A recently published report defined 
the two motifs of the GW182 and PABPC1 interaction and demonstrated that the 
interaction is critical for miRNA-mediated silencing in animal cells (Huntzinger, 2010). 
PABPC1 binds to the Poly(A) tail of eukaryotic mRNAs and interacts with the 
translation initiation factor eIF4G which in turn interacts with eIF4B. The interaction of 
PABPC1-eIF4G induces mRNA circulation which is thought to stimulate mRNA 
translation (Imataka, 1998; reviewed in Jackson, 2010). Therefore, the interference of 
GW182 with this interaction is hypothesized to decrease the rate of translation.  
Furthermore, it was demonstrated that GW182-containing foci coincide with mRNA 
processing bodies (P bodies) (Eystathioy, 2003). P bodies are granules which consist 
of proteins involved in mRNA decay and translational repression (see section 3.6.). 
mRNAs which undergo repression or degradation are accumulating in P bodies 
(reviewed by Eulalio, 2007b). It was shown in D. melanogaster that the accumulation 
of GW182 proteins in P bodies requires the AGO-binding domain and the Q-rich 
region of the protein (Eulalio, 2009a). The accumulation of GW182 in detectable P 
bodies is not required for translational repression though (Eulalio, 2007c). 
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3.5.3. HPat 
 
HPat is a general decapping activator in D.melanogaster and conserved in 
eukaryotes. As described in section 3.4.2, DCP2 needs additional proteins for 
efficiently decapping mRNAs (Bai, 2006; Simon, 2006) and one of them is HPat. 
HPat has been found to interact with the decapping activators Me31B, DCP2, the 
LSm1-7 complex and the CCR4-NOT deadenylase complex in D. melanogaster 
(Haas, 2010). Functional studies suggest that HPat might link decapping and 
deadenylation. A recently published study performed in human cells made similar 
observations for Pat1b, the human HPat ortholog (Ozgur, 2010). Co-depletion of 
HPat and Me31B strongly inhibits miRNA-mediated decapping (Eulalio, 2007a). 
Recently, HPat has been found to co-purify with the miRNA effector protein GW182 
in D. melanogaster cells (Jäger, 2010).  
Further, the protein has been found to localize to P bodies in yeast, Drosophila and 
human cells (Pilkington, 2008; Eulalio,2007c; Ozgur, 2010), similar to other factors of 
the mRNA decay machinery. 
(Haas, 2010) 
Figure 3.7.: Domain organization of HPat from Drosophila melanogaster 
The protein consists of an N-terminal region (N-ter), a glutamine/ prolin-rich region (P-rich), a 
middle domain (Mid) and the C-terminal domain (Pat-C). The numbers represent the 
aminoacid positions. 
 
HPat proteins are characterized by a conserved N-terminal region, a prolin-rich 
domain, the Mid region and the C-terminal domain (figure 3.7.). The decapping 
activator Me31B binds to the N-terminal domain of HPat (Haas, 2010). The prolin-rich 
domain was found to be necessary and sufficient to trigger deadenylation and 
decapping of bound mRNAs. Furthermore this domain is required for P body 
localization. The Mid domain is required for the interaction of HPat with CCR4 and 
LSm1-7. Moreover, complementation assays demonstrated that the Mid and PatC 
domains are required to restore decapping in cells depleted of HPat (Haas, 2010). 
Thus, HPat was suggested as bridging factor between deadenylation and decapping. 
The co-purification of HPat with GW182 might hint towards a link to the general 
degradation machinery, nevertheless this is still very speculative since functional 
evidence is missing. 
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3.6. Cellular compartmentalization of miRNA repression:    
P Bodies 
Translationally repressed mRNAs can accumulate in granules called Processing (P) 
bodies. P bodies are described as cytoplasmatic foci with a very dynamic structure 
(Eystathioy, 2002 and 2003; reviewed in Eulalio, 2007b). Initially, these structures 
were termed GW bodies since they showed an enrichment of the miRNA effector 
protein GW182 (Eystathioy, 2002 and 2003). GW182, Ge-1 and RAP55 (also known 
as LSm14) are markers for P bodies and essential for their integrity (Yang, 2006; Yu, 
2005; Yang, 2004). Number and size of P bodies change during the cell cycle. For 
example, there is a high amount of P bodies in proliferating cells but a low one in 
stationary cells (Eystathioy, 2002). Proteins which are involved in mRNA 
degradation, translational repression, mRNA surveillance and RNA-mediated 
silencing were found to co-localize to P bodies. All proteins which are involved in the 
eukaryotic 5‟3‟ mRNA-decay pathway have been found in P bodies, this includes 
the CCR4-NOT deadenylase complex, the decapping complex, the XRN1 
exonuclease and several decapping activators such as Me31B and HPat (reviewed 
in Eulalio, 2007b). By contrast, exosome components have not been detected in P 
bodies (Sheth, 2003). Moreover, neither ribosomal proteins nor other proteins 
involved in translational initiation localized to P bodies with the exception of the 
translation initiation factor eIF4E (Brengues, 2005; Andrei, 2005). AGO proteins, 
miRNAs and miRNA targets were found in P-bodies, therefore it was hypothesized 
that P bodies may have a role in miRNA-mediated silencing (Ding, 2005; Sen, 2005; 
Pauley, 2006; Liu, 2005). The depletion of P body components leads to their 
macroscopic dispersal but miRNA-mediated silencing is not affected (Eulalio, 2007c). 
Thus, a functional miRNA silencing pathway is essential for the development of P 
bodies but the absence of P bodies does not prevent miRNA-mediated repression. 
That suggests that P bodies are a consequence rather than a cause of miRNA 
silencing (reviewed in Eulalio, 2007b).  
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3.7. Identification of miRNA targets 
The identification of mRNAs which are regulated by miRNAs is one of the first steps 
to understand the mechanisms of miRNA mediated regulation and of the function of 
particular miRNAs. A lot of attention has been given into developing strategies to find 
miRNA targets. There exist several bioinformatic prediction methods, and 
experimental methods. I describe predominantly the experimental approaches in the 
following sections, since these are more relevant for this thesis. 
 
3.7.1. Bioinformatic predictions of miRNA targets 
The computational methods are mainly based on the general rules of miRNA and 
mRNA target interaction. Most algorithms for miRNA target prediction rely on 
complementarity to the miRNA seed region and evolutionary conservation amongst 
species. Furthermore, particular sequence features outside the target motif and the 
free energy of the miRNA-mRNA heteroduplex are often considered. For instance, 
the algorithms TargetScan (Lewis, 2003) and PicTar (Krek, 2005) rely mainly on the 
seed region and evolutionary conservation. miRanda (John, 2004) aligns miRNAs 
and mRNAs, identifying highly complementary sequences, thereby the seed 
complementarity is counted as strong indicator. The potential targets are also 
scanned for the free energy during pairing and conservation. In contrast to the other 
two algorithms, miRanda can also predict targets with a bulge or a G:U wobble in the 
seed region.  
Computational tools have contributed significantly to narrow down the list of potential 
miRNA targets. However, one drawback of computational approaches is that it is not 
known to which extent miRNAs follow the applied principles of target recognition. The 
mechanism of miRNA function is poorly understood and several reports exist about 
miRNAs which are not targeting the 3‟UTR or do not follow the “seed rule” (Nahvi, 
2009; Orom, 2008; Didiano, 2006).  
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3.7.2. Experimental approaches to identify miRNA targets 
 
The experimental approaches to identify miRNA targets include transcriptome and 
proteome analysis as well as biochemical approaches. 
(Orom, 2009) 
Figure 3.10.: Starting points for experimental approaches of miRNA target 
identification 
1) mRNA degradation: Overexpression of miRNAs followed by analyzing degraded mRNAs 
2) Immunoprecipitation of tagged/endogenous proteins of the RISC and analysis of 
associated mRNAs 
3) Affinity purification of tagged miRNAs followed by analysis of the associated mRNAs 
4) Inhibition of initiation/ post-initiation: some miRNA targets shift in non-polysomal fractions 
upon miRNA targeting in polysome analysis 
5) Protein Synthesis: Analysis of the proteome after overexpression or depletion of miRNAs 
 
3.7.2.1. Transcriptome analysis 
The steady-state transcript levels of most miRNA targets are reduced upon miRNA 
repression. Therefore transcriptome analyses after overexpression or depletion of a 
specific miRNA are a useful way to identify potential miRNA targets. For screening 
whole mRNA levels either microarray analysis or deep-sequencing is used usually. 
For example, a study on miR-1 and miR-124 in HeLa cells showed that upon 
overexpression of one of either these miRNAs the gene expression profile changes 
significantly (Lim, 2005). Further a report demonstrated that the proliferation of liver 
and lung cancer cells was decreased by overexpressing the miRNA let-7 which lead 
to a downregulation of around 200 mRNAs (Johnson, 2007). Another study examined 
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the knockdown of the miRNA miR-122 in mice and found a moderate upregulation of 
hundreds of mRNAs (Krützfeldt, 2005).  
Limitations of these methods are that it is difficult to distinguish direct from indirect 
effects and that not all repressed mRNAs show an effect on transcriptome level 
(reviewed in Orom, 2009). 
 
3.7.2.2. Proteome Analysis 
miRNA targets can also be identified by analyzing the proteome. Proteomic 
approaches often use stable isotope labeling with amino acids (SILAC) followed by 
mass spectrometry to examine the effect of depletion or overexpression of a miRNA 
on the protein level. SILAC allows comparing relative protein abundance between 
two cell populations. Thereby, a particular amino acid (e.g. lysine or arginine) is 
substituted with stable isotopic nuclei (e.g. deuterium, 13C). Then the cell 
populations are grown in media substituted either with the “heavy” or the “light” form 
of the amino acid. Upon substitution of the labeled amino acid, it is incorporated into 
all newly synthesized proteins. The proteome is analyzed by mass spectrometry: the 
peptide peak intensities of “heavy” and “light” isotope containing amino acids are 
compared (reviewed in Orom, 2009). SILAC was used in a study which analyzed the 
proteome of HeLa cells overexpressing one of five different miRNAs (Selbach, 2008). 
The effects on the expression pattern of several proteins were significant. 
Additionally, the mRNAs of the most affected proteins harbored also complementary 
seed regions to the respective miRNAs in their 3‟UTR. Another study compared the 
proteomes of neutrophils from wild-type and miR-223 knockout mice. Several 
proteins were overexpressed in the miR-223 knock-out strain. The mRNAs had again 
enriched matches with the seed region of the miRNA (Baek, 2008). In both 
aforementioned studies, the effects obtained on protein level were similar to the 
effects on the mRNA level.  
Similarly to transcriptome analysis, it is difficult to distinguish between direct and 
indirect effects. The disadvantage of the SILAC method is that it is time-consuming, 
expensive and has some practical challenges (reviewed in Thomas, 2010).  
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3.7.2.3. Biochemical approaches 
Biochemical approaches summarize a various amount of methods which are 
continuously increasing. The most extensively used ones are immunoprecipitation 
assays of miRISC proteins, HITS-CLIP, tagging of miRNAs, polysome analysis and 
the recently modified Ribosome profiling.  
 
Immunoprecipitation of miRISC components 
 
As described previously, the miRISC in mammalian cells contains the mature miRNA 
and several proteins (AGO, GW182). It is possible to identify miRNA targets due to 
their association with miRISC proteins by performing immunoprecipitation assays. 
The technique allows purification of a protein of interest from a lysate by using an 
antibody specifically binding the protein. Several studies have used this approach 
(Beitzinger, 2007; Easow, 2007; Zhang, 2007). In one report, tagged AGO1 was 
immunoprecipitated from Drosophila S2 cells (Easow, 2007). The authors could 
reproducibly isolate 89 mRNAs which were enriched in 3‟ UTR seed matches. A 
recently published report used AGO2 for immunoprecipitating cellular miRNA targets 
from (virus-infected) human cells (Dölken, 2010). Similarly, immunoprecipitations of 
the homologs of GW182 (Tnrc6/ AIN-1 and AIN-2) in mammalian cells and C.elegans 
were used to identify miRNA targets (Landthaler, 2008; Zhang, 2007;). The 
immunoprecipitation of miRISC proteins has been used predominantly to describe 
the general features of miRNA target sites and for isolation of interaction partners, 
rather than for identification of particular miRNA targets. However, several of the 
miRNA targets identified have been experimentally validated. Moreover, 
immunoprecipitation assays have been used to identify miRNA targets which do not 
show an effect on mRNA level upon miRNA overexpression (Karginov, 2007) and to 
reveal unexpected miRNA recognition motifs (Hendrickson, 2008).  
The limitations of this method are first that AGO proteins can also associate with 
mRNAs after cell lysis, what could lead to false positive miRNA targets in a pulldown 
(Karginov, 2007). Secondly, for epitope-tagged AGO proteins an association with 
transfer RNAs or snoRNAs has been demonstrated which might be functionally 
relevant and can cause misinterpretations (Maniataki, 2005; Ender, 2008). Thirdly, 
the overexpression of AGO causes an increased production of miRNAs which could 
affect the global picture of miRNA-mRNA interactions (Zhang, 2009). Lastly, for 
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studying only the targets of a particular miRNA, the procedure has to be adapted 
since in an immunoprecipitation analysis all miRNAs associated to the miRISC 
component are examined.  
 
High throughput sequencing by crosslinking and immunoprecipitation (HITS-CLIP) 
 
In this method, nucleic acids are crosslinked to miRISC proteins by ultraviolet (UV) 
irradiation, followed by immunprecipitation of miRISC proteins with a specific 
antibody e.g. against AGO. The RNA is digested resulting in RNA fragments which 
have been protected by the particular miRISC protein. Finally, the fragments are 
analyzed by high-throughput RNA sequencing and thereby the miRNAs and miRNA 
targets are identified (reviewed in Thomas, 2010). HITS-CLIP was used to study 
miRNA targets in C. elegans (Zisoulis, 2010). The study found a large amount of 
potential miRNA targets and a majority of these mRNAs contained seed region 
matches to the isolated miRNAs. However, bioinformatic analyses demonstrated that 
around 37% of the putative miRNA targets lacked a conserved seed match, 
indicating that the method is useful also for identifying targets which do not follow the 
general rules. PAR-CLIP (photoactivatable-ribonucleoside-enhanced crosslinking 
and immunoprecipitation) is an adapted version of the HITS-CLIP method and has 
been used successfully for miRNA target identification (Hafner, 2010). Thereby, cells 
are grown in media containing photoreactive 4-thiouridine which substitutes uridine 
during transcription. The following procedure is basicly as normal HITS-CLIP: the 
miRISC proteins are cross-linked, immunprecipitated and the RNA is digested. The 
protein-bound miRNAs and mRNAs are analyzed by high-throughput sequencing 
(reviewed in Thomas, 2010). PAR-CLIP was used for a study in human cells in which 
tagged AGO 1-4 were used to identify around 20000 enriched sequences. The 
majority of these sequences matched the seed sequence of some strongly 
expressed miRNAs. Around 46% of the miRNA binding motifs were located in the 
3‟UTR.  
HITS/PAR-CLIP are technically challenging, but allow a genome-wide and direct 
study of miRNA targets-sites (reviewed in Thomas, 2010). 
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miRNA tagging 
 
Another experimental approach for miRNA target identification is the isolation of 
mRNAs directly bound to tagged miRNAs. Thereby, a particular miRNA is labelled 
(e.g. with biotin) and transfected into cells. Then the labelled miRNA with its 
associated RNAs can be isolated (reviewed in Orom, 2009). Using this method, 
particular miRNA:mRNA target interactions have already been validated 
(Christoffersen, 2009). Furthermore, a study identified novel targets of miR-10a with 
this approach (Orom, 2008). Thereby, miRNA and mRNAs were cross-linked 
followed by primer extension mapping of the miRNA binding site. The study 
demonstrated further that miR-10a can target mRNAs in their 5‟UTR and enhance 
their translation by non-seed interactions  
Thus, by using this approach a particular miRNA-mRNA target interaction can be 
studied also with respect to its binding motif and the location of the binding site.  
 
 
Polysome Analysis 
 
Another method which might have potential for the identification of new miRNA 
targets is polysome analysis. Polysomes are ribosome clusters bound to one mRNA 
and suggested to reflect the degree of translation of a particular mRNA. In the 
experimental procedure cell lysates are separated by sucrose density gradient 
analysis (see section 6 background of this thesis). The polysomes and other 
compounds migrate in the gradient according to their relative molecular weight. The 
gradient can be fractionated allowing the separation of mRNAs associated to 
polysomes or monosomes from mRNAs in the ribonucleoprotein fractions (RNPs).  
For finding novel miRNA targets by this method it has to be assumed that repressed 
miRNA targets shift to the RNP fractions of the density gradient. As mentioned in 
previous sections, some polysome analysis studies found miRNA targets co-
migrating with ribosomes (Nottrott, 2006; Petersen, 2006) while others found them 
shuttling into the RNP fractions upon miRNA repression (Huang, 2007; Pillai, 2005). 
Despite this controversy, the method was used successfully for miRNA target 
identification in the HepG2 human cell line by Nakamoto and co-workers (Nakamoto, 
2005). In that study, specific endogenous miRNAs were knocked down which lead to 
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a shift of several mRNAs (miRNA targets) into the heavy polyribosomal fractions of a 
gradient. The shift was reflected also in higher protein levels of the targets.  
In my knowledge, this is the only report demonstrating a successful identification of 
miRNA targets by polysome analysis.  
 
 
Ribosome Profiling 
 
A recent study extended ribosome profiling to analyze miRNA mediated repression in 
mammalian cells (Guo, 2010). The method is based on deep sequencing of ribosome 
protected mRNA fragments (RPFs). First, cells are treated with cycloheximide to 
arrest translating ribosomes. The RNA is digested from the cell extracts what results 
in 80S monosomes. These are purified over sucrose density gradients. The RPFs 
are released and the remaining fragments are analyzed by high-throughput 
sequencing. The study compares the effects of miRNAs mRNA level by ribosome 
profiling to the simultaneously measured effects on protein level by performing 
pSILAC. Endogenous and ectopic miRNA targeting interactions were under 
examination. The outcome indicates that in most of the cases, decreased mRNA 
levels lead to decreased protein production rather than mRNA repression. Further, it 
is demonstrated that the method allows determining the positions of ribosomes on 
mRNAs very precisely. The authors claim that Ribosome profiling is advantageous 
since genes which are not detected by proteomic methods can be analyzed 
quantitatively and the status of a cell at a particular time point is reported.  
 
 
Thus, the spectrum of available experimental and computational approaches is quite 
broad. Which method to choose depends on the research question that should be 
answered. In many studies, different methods are combined which seems to increase 
the success rate. For instance Lal and co-workers (Lal, 2009a and 2009b) performed 
a study in human cells which successfully combined bioinformatic and experimental 
tools for miRNA target identification. The study examined the function of miR-24 in 
HepG2 cells. Putative miR-24 targets were found by overexpressing the miRNA and 
screen for downregulated genes. From these potential target genes 40% were 
predicted by the bioinformatic prediction algorithm TargetScan and half of them had 
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miR-24 complementary seed in their 3‟UTR. Next, another bioinformatic approach 
was used to analyze the interactome formed by the downregulated genes upon miR-
24 overexpression. Many of these genes were identified as key elements of cell cycle 
regulation and DNA damage repair. In order to verify the predicted targets regulated 
by miR-24, luciferase assays were performed.  
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4. Material and Methods 
 
4.1. Material  
4.1.1. General Chemicals 
 
Name Company 
Aceton AnalaR Normapur, Fr 
Acrylamide 37,5/1 Gerbu, D 
Acrylamide 19/1 Gerbu, D 
Agarose Fisherbrand,D 
Ammoniumchloride AppliChem, D 
Ampicillin Sigma 
APS (Ammoniumpersulfate) Serva, D 
Boric acid Gerbu, D 
BSA (Bovine Serum Albumin) Sigma 
Bromophenol Blue Merck, D 
Chloroform AnalR Normapur, Fr 
Coumaric acid Sigma 
Cycloheximide Sigma 
Complete Protease Inhibitor EDTA-free Roche 
Complete Protease Inhibitor Roche 
Disodiumhydrogenphosphate AppliChem 
DTT (Dithiothreitol) Sigma 
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DNA-Loading Dye NEB, UK 
dNTP Mix Jena Bioscience 
Ethanol 96% Carl Roth GmbH, D 
EDTA (Ethylenediaminetetraacetic acid) pH 8 AppliChem, D 
Ethidiumbromide Merk, D 
Ficoll 400 Pharmacy AB,  
Fluorinert FC 40 Perfuoro Compounds 
Formaldehyde Merck, D 
Glacial acetic acid (CH3COOH) AppliChem, D 
Glycerol AppliChem, D 
Glycine AppliChem, D 
Glycogen PeqLab, D 
Heparin Sigma, US 
Hydrochloric acid AppliChem, D 
Hydrogenperoxide (H2O2) Aldrich 
Hygromycin B Roche 
Iodophenylboronic acid (4-IPBA) Aldrich 
Igepal Ca-630 (NP40) Sigma, US 
Isopropanol AnalaR Normapur 
Luminol Fluka 
Magnesiumchloride (MgCl2) AppliChem, D 
Methanol Emsure, D 
Milk Powder AppliChem, D 
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MOPS (3-Morpholinopropane-1-sulfonic acid) AppliChem, D 
Phenol AppliChem, D 
Potassium chloride (KCl) AppliChem, D 
Potassiumhydrogenphosphate (KH2PO4) Gerbu, D 
Sodiumacetate (NaOAc) Merck, D 
SDS (Sodium Dodecylsulfate) Serva, D 
Sucrose 4x for density gradients Gerbu, D 
TEMED (Tetramethylethylenediamine)  Fluka, D 
Trichlor-acetic-acid (TCA) Sigma, D 
Tris Base (Tris(hydroxymethyl)aminomethan) AppliChem, D 
Trizol LS Sigma, US 
Tween 20 Merk, D 
Tryphanblue Sigma 
Urea Gerbu, D 
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4.1.2. Enzymes 
 
Enzyme Units Company Kat.# 
M-MLV Reverse Transcriptase 200U/µl Promega #M1705 
NEB Taq Polymerase 5U/µl New England BioLabs #M0267 
GoTaq DNA Polymerase 5U/µl Promega #M3178 
Proteinase K 21mg/ml Fermentas #E00491 
Restriction Enzymes  New England BioLabs  
RiboLock RNase Inhibitor 40U/µl Fermentas #E00381 
RQ DNase I, RNase-free 1U/µl Promega #M6101 
 
4.1.3. Antibodies 
Primary Antibodies Working dilution Clone (company) 
Anti-Myc rabbit polyclonal 1:1000 – 1:3000 C3956 (Sigma) 
Anti-HA mouse monoclonal 1:1000 16B12 (Covance) 
Secondary Antibodies Working dilution Clone (company) 
Anti-mouse HRP 1: 10000 115035008 (Jackson 
Immuno Research 
Laboratories) 
Anti-rabbit HRP 1: 10000 111035008 (Jackson 
Immuno Research 
Laboratories) 
 
All primary antibody dilutions were made in 1x PBS containing 0.05% Tween and 0.02% 
Natriumazide (NaN3). 
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4.1.4. Primers 
Gene Name Sequence 5’-3’ 
Tm 
(°C) 
Product 
length 
(Bp) 
Bantam 
SD251 GTGCAGGGTCCGAGGT 57.5 
49 
SD252 CCAGCTGGGTGAGATCATTTTGAAAG 58 
Firefly 
luciferase 
SD247 CAAAGGATATCAGGTGGCCC 55.5 
322 
SD248 GCCCTTCTTGGCCTTTATGAG 56 
Hid 
SD242 GCGGCCAGACGCAAGCGATTGACC 66.8 
310 
SD243 CGTTCTCGCTCCACCTGTCGCTGCTG 66.7 
Renilla 
luciferase 
SD327 GGAAACGGATGATAACTGGTC 62 
278 
SD328 CCATTACCAGATTTGCCTGAT 62 
RP49 
SD188  CACAAATGGCGCAAGCCCAAGGGTATCG 64 
166 
SD189  GGACCTCCAGCTCGCGCACGTT 62 
Vha68 
SD221 GGTATCCGGACCAGTGGTCA 58.7 
271 
SD222 GGTCATGACACCAATGTCCCG 58.3 
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4.1.5. Plasmids  
All plasmids I used in my experiments were generously provided by the lab. 
 
Renilla luciferase: pAc5.1C-Rluc-V5His6 
The plasmid (figure 4.1) was used to express Renilla luciferase in dual-luciferase 
assays using miRNA sensors. The pAc5.1C-RLuc-V5His6 was initially constructed by 
Elisa Izaurralde (Rehwinkel, 2005). The plasmid contains an ampicillin resistance 
gene for selection in E. coli and a pUC ori (origin of replication) for propagation in 
E.coli. For expression of Renilla luciferase the RLuc gene was inserted after an 
Actin5C promoter and before an SV40 terminator containing a polyA signal. A 
detailed plasmid description is available on the internet (www.addgene.org/21182) 
 
 
Figure 4.1.: Renilla luciferase plasmid  
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pAc Fluc-nerfin 
This plasmid (figure 4.2) was used to express firefly luciferase in dual-luciferase 
assays using miRNA sensors. pAc Fluc-nerfin contains an ampicillin resistance gene 
for selection in E. coli and a pUC ori (origin of replication) for propagation in E.coli. In 
order to express the firefly luciferase nerfin in Drosophila tissue culture an Actin5C 
promoter is on the plasmid. The firefly luciferase gene (from P. pyralis) is fused to the 
3‟UTR of the Nerfin-1 gene (D. melanogaster). The 3‟UTR of the Nerfin-1 gene 
harbors also a polyA signal which is necessary for stability and expression in 
eukaryotes. 
 
 
 
Figure 4.2.: Firefly luciferase Nerfin plasmid 
  Material and Methods 
   41 
pAc 5.1/V5-His (Invitrogen) 
This plasmid was used as empty vector control in dual-luciferase assays using 
miRNA sensors. pAc 5.1 contains an ampicillin resistance gene for selection in E.coli 
and a pUC ori (origin of replication) for propagation in E.coli. The gene of interest can 
be introduced in the MCS (multiple cloning site) between a Actin5C promoter and an 
SV40 terminator with a poly A signal. Thus the vector can be used for expressing the 
gene of interest in a eukaryotic in culture system. 
 
 
 
 
 
 
 
 
 
Figure 4.3.: pActin 5.1 plasmid 
 
pAc mir9b  
The plasmid was used to overexpress the miRNA miR9b in dual-luciferase assays. 
miR9b genes were introduced into the MCS of the pActin 5.1 plasmid (see figure 
4.3.). 
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Plasmids used in the protein studies 
For generating the following plasmids, the cDNAs were amplified by PCR from 
cDNAs of Drosophila S2 cells or cDNA clones from the Drosophila Genomic 
Resource center and subsequently recombined into pDONR221 (Invitrogen). These 
clones were used as entry vectors for LR recombination (described in figure 4.4) into 
the expression (destination) vectors pAMW or pAHW from the Drosophila Gateway 
Vector Collection (Carnegie Institution). The pAMW vector contains an Actin5C 
promoter, a SV40 PolyA site, an ampicillin resistance and a 6 x Myc tag. After 
recombination with the entry clone of interest the Myc tag is located at the N-terminus 
of the ORF of interest. The pAHW vector contains an Actin5C promoter, a SV40 
terminator, an ampicillin resistance and a 3 x HA tag. After recombination with the 
entry clone of interest, the HA-tag is located at the N-terminus of the ORF of interest. 
 
 
Figure 4.4.: The Gateway LR in vitro recombination reaction (Invitrogen) 
The entry clone containing the open reading frame (ORF) of interest is recombined with the 
destination vector containing the Gateway recombination cassette (containing a ccdB gene). 
A lambda integrase is used to recombine the recombination sites on the vectors: attR1 and 
attR2 with attL1 and attL2. The result is a fusion gene with the ORF of interest placed in 
frame with an epitope tag in the destination vector (expression clone). The destination 
vectors in these experiments had either an HA-tag (destination vector pAHW) or a Myc-tag 
(destination vector pAMW). Successfully recombined clones can be selected based on their 
resistance to ampicillin and lack of toxicity to standard laboratory strains of E.coli. 
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Expression clones derived from a pAHW destination vector: 
 
pEJ144 – Ago1 (CG6671) 
pEJ55 – GST 
pEJ26 – HPat (CG5208) 
pSD434 – L23A genomic (CG7977) 
pSD429 – L11 genomic (CG7726) 
 
Expression clones derived from a pAMW destination vector: 
 
pSD355 – CCR4 (CG31137) 
pEJ104 – Ago1 (CG6671) 
pEJ27 – HPat (CG5208) 
pEJ91 – DCP1 (CG11183) 
pEJ30 – GW182 (CG31992) 
pEJ25 – Me31B (CG4916) 
pEJ54 – GST 
pSD438 – L11 genomic (CG7726) 
pSD439 – L23A genomic (CG7977) 
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4.1.6. Buffers, Solutions and media 
 
4.1.6.1. Cell Culture 
 
S2 Complete Medium:  Company 
S2 Drosophila Schneider‟s Medium  Lonza 
10% Fetal Bovine Serum (FBS)  Sigma  
Penicillin (100U/ml)  Sigma 
Streptomycin (100µg/ml)  Sigma 
2 mM Glutamine  Sigma 
Medium was sterile filtered and stored at 4°C (for 4 weeks maximum). For passaging the 
cells, the media was warmed up to room temperature. 
 
Hygromycin Medium for stable cell lines:  Company 
S2 Drosophila Schneider‟s Medium  Lonza 
10% Fetal Bovine Serum (FBS)  Sigma 
Penicillin (100U/ml)  Sigma 
Streptomycin (100µg/ml)  Sigma 
2 mM Glutamine  Sigma 
150µg/ml Hygromycin B  PAA 
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10x PBS (Dulbecco‟s Phosphate buffered saline) pH 7.2 
1.37 M NaCl 
27 mM KCl 
81 mM Na2HPO4  
14.7 mM KH2PO4  
 
4.1.6.2. Solutions and Buffer for Polysome Gradients 
 
10x Gradient Buffer  
200 mM Tris/HCl (pH 7.5) 
1.5 M NH4Cl 
100 mM MgCl2 
 
4.1.6.3. Solutions for RNA-Isolation  
 
10% w/v SDS (Sodiumdodecylsulfate) 
Stock was prepared RNase-free. 
 
3 M NaOAc (Sodiumacetate) pH 5.2 
pH was adjusted RNase-free using CH3COOH (glacial acetic acid) 
 
Glycogen: 35mg/ml (PeqLab 37-1810) 
Stock was diluted to 10mg/ml 
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4.1.6.4. Denaturing Polyacrylamide Gel: 15% PAGE/UREA 
 
20x TBE (Tris/Borate/EDTA) pH 8  
1.8 M Tris Base 
1.8 M Boric acid 
40 mM EDTA 
 
4.1.6.5. Loading Dyes 
 
5x DNA Agarose Dye 
20% w/v Ficoll 400 
1 mM EDTA 
0.1% w/v SDS 
0.05% w/v Bromophenol Blue 
 
4.1.6.6. Protein Precipitation using TriClorAcetic Acid (TCA) 
 
TCA Solution  
71.4 g TCA were dissolved in 50ml ddH2O 
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4.1.6.7. SDS-PAGE 
 
10x Laemmli (GTS Running Buffer) 
1.92 M Glycine  
250 mM Tris base  
1% w/v SDS  
 
10% w/v APS (ammoniumpersulfate) 
 
2x SDS Laemmli Protein sample buffer 
100 mM Tris/HCl pH 6.8 
4% w/v SDS 
20% w/v Glycerol 
0.2 M DTT 
0.05% w/v Bromophenol Blue 
 
4.1.6.8. Western Blotting and Immunostaining 
 
10x Transfer Buffer pH 8.3  
250 mM Tris Base 
1.92 M Glycin  
If a nitrocellulose membrane was used the 1 x transfer buffer contained also 20% 
MeOH. 
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Membranes 
GE Hybond-P PVDF Membrane 
Nitrocellulose Membrane (for the co-immunoprecipitation experiments) 
 
1x PBS with 0.05% w/v Tween 
 
Detection Solution for Western blotting 
100 mM Tris/HCl pH 8.0 
0.2 mM p-Coumaric acid 
1.25 mM Luminol 
 
6 µl of Hydrogenperoxide (H2O2) per 1ml detection solution were added directly 
before use. 
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4.1.6.9. Agarose gel electrophoresis 
 
50x TAE (Tris/acetic acid/ EDTA) 
2 M Tris Base  
50 mM EDTA 
5.1% v/v glacial acetic acid  
 
4.1.6.10. Pelleting of ribosomes 
 
1.5 M Sucrose Solution 
Solution was prepared in 1x Gradient Buffer (from polysome gradients see section 
2.1.6.2.) and milliQH2O. 
 
2.1.6.11. Co-Immunoprecipitation 
 
Protein A Sepharose Beads CL-4b from GE Healthcare covalently cross-linked to 
anti-HA antibody clone 12CA5. Elisabeth Jäger prepared the beads and provided 
them generously for my experiments. 
 
NET 150 (lacking EDTA) 
50 mM Tris/HCl pH 7.5 
150 mM NaCl 
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4.2. Methods 
 
4.2.1. Cell culture 
 
Cell lines 
Drosophila S2 cells Invitrogen 
 
Drosophila S2 stable cell line expressing TAP-tagged GW182 
Drosophila S2 stable cell line expressing TAP-tagged HPat 
Drosophila S2 stable cell line expressing TAP-tagged AGO1 
 
All cells were routinely grown at 25°C. The cells were always passaged in a density 
higher than ~ 1-2 x 106 cells per ml. 
The stable cell lines were generated by the lab using the pMK33/pMtHy plasmid. 
After 3-4 weeks of selection in medium containing 300µg/ml hygromycin B a cell line 
stably expressing the protein of interest is obtained. Then the cell lines were 
transferred and maintained in medium containing 150µg/ml hygromycin B. The 
protein of interest is under an inducible metallothionine promoter. In order to induce 
the expression of the stably integrated gene, CuSO4 was added to the cells to a final 
concentration of 0.5 mM (e.g. 5 µl of 0.1 M CuSO4 per ml cultured cells). The cells 
were harvested 2-3 days after induction. 
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Cell counting using a Neubauer Hematocytometer 
 
First a 1:10 dilution of the cells was prepared. Therefore, 70 µl 1x PBS were mixed 
with 20 µl 5x Trypanblue and 10 µl cells. From this dilution, 20 µl were applied to a 
tightly sealed Hematocytometer (see figure 4.5). The cells in the 4 large corner 
squares were counted under the microscope and the outcome was calculated to 
cells/ml according the formula: 
Σ cells counted in all 4 squares/ 4 x 10000 x 10 = cells/ml 
www.nexcelom.com/images/Counting_Grid.gif  
Figure 4.5.: Scheme of a Neubauer Hematocytometer 
 
Transfection of Drosophila S2 cells 
 
For all transfections I used Effectene Transfection Reagent (Quiagen). First, the 
desired cell amount (usually 2 – 3 x 106 cells per 6-well) was seeded into a well of a 
6-well plate. The cells were kept at 25°C for 15-30 minutes to settle down. In the 
meantime the plasmids were prepared in eppendorf tubes in the desired 
concentrations. 
The following reagents were added into the tube per 1 µg DNA. First 150 µl EC 
Buffer and 8 µl Enhancer were added. The suspension was mixed by pipetting and 
incubated 5 minutes at room temperature. Then 25 µl Effectene were added, and 
again the solution was mixed by pipetting and incubated for 10 minutes at room 
temperature. After adding 600 µl of S2 complete medium the mixture was applied 
dropwise onto the settled cells. The 6-well-plate was sealed with parafilm and kept at 
25°C for 3 days. 
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4.2.3. Transformation 
 
For all transformations, rubidium chloride competent cells of E.coli strain DH5α-T1 
from Invitrogen were used (genotype: F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
recA1 endA1 hsdR17(rk-, mk+) phoA supE44thi-1 gyrA96 relA1 tonA). The 
competent cells were thawn on ice. In order to transform, 20-30 µl competent cells 
were added to 250ng plasmid DNA. Then the cells were incubated on ice for 30 
minutes. This was followed by a heat-shock for 45 seconds at 42°C. Afterwards the 
cells were cooled immediately on ice for 2 minutes. Around 10 µl of the transformed 
cells were added to a droplet of LB medium on an LB-ampicillin plate and sterile 
glass beads were used for platting. The whole procedure was done beside the flame 
to avoid contaminations. The LB-ampicillin-plates were incubated overnight at 37°C. 
Colonies were picked the next day and the plates were stored for further usage at 
4°C. 
 
4.2.4. Preparation of Plasmid DNA 
 
Colonies from the culture plates were picked with a sterile toothpick and inoculated in 
50ml LB medium containing 100µg/ml ampicillin. The cultures were grown on the 
shaker at 37°C overnight. Plasmids were isolated using the Qiagen Plasmid Plus 
Midi Kit (Cat. # 12945) according manufacturer‟s instructions. The procedure starts 
with an alkaline lysis of the cultured cells. Then the cleared lysate is loaded onto a 
spin column were plasmid DNA binds to the matrix by a silica based mechanism. 
Particular washing buffers in the procedure ensure that the plasmid DNA is free of 
contaminants such as RNA, proteins and genomic DNA.  
The plasmid concentrations were determined using a NanoDrop Photospectrometer 
assaying also the purity of the DNA by measuring the 260/280nm and 260/230nm 
ratios. 
In order to confirm the identity of the prepared plasmids, restriction digests were 
performed. Therefore enzymes from NEB were used according manufacturer‟s 
instructions.  
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Example restriction digest: 
For a digest, 2 Units of restriction enzyme per µg DNA were used with the 
appropriate buffer (according NEB catalogue). H2O and BSA (bovine serum albumin) 
was added to the digest if suggested by the NEB catalog. The restriction digests 
were kept for 1 hour at 37°C and analyzed on 1-1.5% agarose TAE gels. 
 
4.2.5. Polysome Gradients 
 
a) Cell harvest and cycloheximide incubation 
Drosophila S2 cells were grown in T75 suspension flasks to a density of 9-10 x 106 
cells/ml. In order to have a large amount of polysomes, the cells should be in the 
logarithmic growth phase. Cycloheximide was added to a final concentration of 0.1 
mg/ml to the cells and incubated for 20 minutes at 25°C. Cycloheximide is necessary 
to keep the polysomes intact during the procedure.  
 
b) Gradient Preparation 
The 15 % and 45 % sucrose solutions were prepared in 1 x gradient buffer (see 
section 4.1.6.2.) supplemented with 1 mM DTT and 0.1 mg/ml cycloheximide just 
before usage. In order to prepare the gradient 6 ml of the 15 % sucrose solution were 
layered carefully on top of 6 ml of the 45 % sucrose solution in polyallomer SW40Ti 
tubes. A linear 15-45 % gradient was formed using the Gradient Master (Biocomp) 
with the program SW40 15-45 % long sucrose.  
 
c) Lysate Preparation 
 
Components of the isotonic lysis buffer 
In the isotonic lysis buffer Tris/HCl with a pH of 7.5 is necessary to keep the pH 
stable in the lysate. Ammonium chloride (NH4Cl) and Magnesiumcloride (MgCl2) 
stabilize the ribosomes and protect them from falling apart. Igepal is a detergent 
which lyses the cells by disrupting membranes mainly. Dithiothreit (DTT) is also a 
detergent and besides protects from unwanted oxidation reactions in the sample. 
Heparin is a good RNase inhibitor but disrupts also miRNA:mRNA interactions. Thus, 
the heparin concentration was reduced greatly in the isotonic lysis buffer compared 
to the original protocol. The antibiotic agent cycloheximide stalls translation and 
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keeps ribosomes from running-off the mRNAs. Cycloheximide acts by blocking the 
movement of peptidyl-tRNA from acceptor site to the donor site on ribosome 
(McKeehan, 1969). The Proteinase Inhibitor inhibits the action of proteinases in the 
sample. The inhibitor needs to be EDTA-free, since EDTA complexes Mg-ions which 
cause the polysomes to fall apart. The RiboLock enzyme is a very efficient RNase 
Inhibitor. 
 
Isotonic lysis buffer 
20 mM Tris/HCl pH 7.5 
150 mM NH4Cl 
5 mM MgCl2 
1% w/v Igepal 
2 mM DTT 
0.01 mg/ml Heparin 
1 x Complete PI EDTA-free 
0.25 U/µl RiboLock 
1 mg/ml Cycloheximide 
 
During the cycloheximide incubation, the lysis buffer was prepared and stored on ice. 
After incubation, the cell suspension was transferred into ice-cold falcon tubes and 
centrifuged at 188 x g for 5 minutes at 4°C. Next, the cell pellet was washed with ice-
cold 1 x PBS supplemented with 0.1 mg/ml cycloheximide. After a quick-spin (at 
16100 x g) for 8 seconds at 4°C, the cells were resuspended in isotonic lysis buffer 
by pipetting up and down. The amount of lysis buffer used was roughly oriented on 
the total cell amount: 250 µl lysis buffer for 30 x 106 cells. Cells were lysed 10 
minutes on ice. The lysate was cleared from cell debris and unlysed cells by 
centrifugation at 10000 x g for 10 minutes at 4°C.  
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d) Centrifugation 
The supernatant was layered dropwise onto the gradient. Input for protein analysis 
was kept beforehand. The tubes were transferred into pre-cooled swinging buckets of 
the SW40TI rotor and balanced. The tubes were closed carefully and centrifuged in a 
Beckman L80 Ultracentrifuge at 36000rpm for 2 hours at 4°C. After centrifugation, 
the buckets were kept on ice until the fractions were collected. 
 
e) Collection of fractions 
The polysome gradients were fractionated using a UA-6 detector with a 254 nm filter, 
a tube piercing system, a syringe pump (Brandel) and fraction collector (Soil 
Measurement system). The UV lamp was pre-warmed, the tube was pierced, and 
Fluoriniert was pumped into the tube from the bottom. Fluoriniert is a high density 
chase solution and was used to push the sucrose gradient into the fractionation 
system. Before fractions were collected the UV-lamp of the machine measured the 
OD 254 nm resulting in a spectrum. The sensitivity of the UV-detector was set to 0.5 
and the speed of drawing the spectrum was 60 cm per hour. Fractions of 500 µl each 
were collected and stored on ice immediately (24 fractions in total). 
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4.2.6. Measuring the luciferase activities  
 
In order to measure the Firefly and Renilla luciferase activities, samples of S2 cells 
transfected with pFluc-nerfin and pRluc were collected 3 days after transfection. 
From each cell population 100 µl were transferred into a 24-well. After the cells were 
settled, they were carefully washed three times with 100 µl 1 x PBS each. After the 
last washing step 100 µl of 5 x Passive Lysis Buffer (Promega) per well were added 
to the cells. For a proper lysis, the cells were kept on the shaker at 4°C for 15-30 
minutes. It was examined under the microscope whether most cells have been lysed. 
For measuring the luciferase activity 10 µl from the sample were transferred into a 
96-well plate. The substrates for the luciferases (luciferase assay reagent from 
Promega) were added and measured in a Luminometer (Robin Solaris) which was 
used according manufacturer‟s instructions. 
 
Conditions of measuring: 
a) Priming 
Prime Injector: 1  
Volume: 200µl 
Speed: 100% 
Cycles: 3 
 
b) Shake 
Shake for 2 seconds 
Mode: linear 
Radius: 5.0 mm 
Speed: 75% 
 
c) Injection 
Injector: 1 
Volume: 50µl 
Dispense: Speed: 45; 
Start: 35; Stop: 45; Accel.: 
400; S.Backl.: 11 
Aspirate: Speed: 45; Start: 
33; Stop: 33; Accel.: 400 
d) Measure luminescence 
Result ID: firefly or renilla 
Integration time: 10.000 
seconds 
Reading Mode: top 
 
e) Process well-by-well 
Injector: 2 
Dispense: Speed: 150; 
Start: 66; Stop: 100; 
Accel.: 800; S.Backl.: 11 
Aspirate: Speed: 45; 
Start: 33; Stop: 33; 
Accel.: 400 
f) Background substraction 
Blank on air 
Blank calculation on final 
results only 
End Process well-by-well 
Result determination 
Result: Firefly/Renilla 
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4.2.7. RNA-Isolation from sucrose gradient fractions 
 
First, the proteins were digested from the samples by performing a proteinase K 
digest. In order to isolate the RNA, the ribosomes have to dissociate from the RNA. 
Therefore, SDS was added to the samples to a final concentration of 1% w/v and 
EDTA to a final concentration of 5 mM. Next, a Proteinase K digest was performed 
(the previously added SDS increases the activity of the enzyme). Proteinase K was 
added to a final concentration of 50 µg/ml to each sample. The tubes were incubated 
at 37°C for 30 minutes. Afterwards the fractions were stored on ice and RNA isolation 
was performed. 
Therefore, 700 µl Trizol LS were added to 300 µl sucrose fraction. The samples were 
shaken and kept 5 minutes at room temperature. Next, 200 µl chloroform were added 
and the tubes were shaken vigorously by hand for 15-30 seconds. The samples were 
kept on room temperature for another 3 minutes. In order to separate the phases the 
samples were centrifuged at 12000 x g for 15 minutes at 4°C. The nucleic acids are 
in the aqueous phase while the proteins/lipids remain in the organic phase. In order 
to precipitate the RNA, the supernatants (ca 600 µl) were transferred to tubes 
containing 500 µl isopropanol and 1 µl glycogen in a final concentration of 0.02 µg/µl. 
Glycogen is used as a carrier to increase RNA yields. The samples were incubated 
10 minutes at room temperature followed by a longer incubation at -20 °C (10-60 
minutes). Then the samples were centrifuged at 12000 x g for 10 minutes at 4°C. The 
supernatant was removed and the pellet washed with 1 ml of ice-cold 75 % ethanol. 
The supernatant was removed again and the pellet was briefly air-dried and 
resuspended in 42.5 µl milliQ water. 
 
4.2.8. DNase I Digest 
 
In order to remove DNA contaminations from the samples, the RNA isolation was 
followed by a DNase I digest. To each sample 5 µl 10 x RQ buffer, 0.5 µl Ribolock 
(40 U/µl) and 2 µl RQ RNase-free DNase I (1U/µl) were added and mixed gently. The 
tubes were incubated at 37°C for 30 minutes. Then the samples were stored on ice 
and 150 µl milliQ water was added.  
The RNA was purified by extraction with 200 µl phenol:chloroform:isoamylacohol 
(25:24:1) followed by an extraction with 200 µl chloroform. Generally, phenol is a 
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protein denaturant which facilitates removing proteins from nucleic acids during 
extractions. Chloroform stabilizes the interphase during extraction and facilitates the 
removal of lipids and proteins. IAA prevents foaming of the solution during mixing 
and additionally enhances phase separation (see bibliography: ambion homepage).  
The RNA was precipitated with 3 volumes absolute ethanol, 0.1 volume of 3 M 
sodium acetate (NaOAc, pH 5.2) and 1 µl glycogen in a final concentration of 0.015 
µg/µl. The tubes were kept 1 hour at – 20°C. Next the samples were centrifuged at 
16 100 x g for 20 minutes at 4°C. The supernatant was removed and the pellet was 
washed with ice-cold 75 % ethanol. Again, the supernatant was removed and the 
pellet was air-dried briefly and resuspended in 20 µl milliQ water. The RNA 
concentrations were determined using a Nanodrop Spectrophotometer measuring 
adsorption at 230 nm, 260 nm and 280 nm. 
 
4.2.9. Reverse Transcription of RNA into cDNA 
 
In order to detect a particular mRNA in the sucrose fractions, the total RNA was 
transcribed into cDNA followed by PCR of the target gene. 
Each RNA sample was diluted with milliQ water to the same concentration for the 
reverse transcription (100 ng or 500 ng per reaction). Further, each sample was 
prepared in a duplicate in order to perform a control reaction without adding the 
reverse transcriptase. Then, random hexamer primers (Fermentas) were added to 
the samples in concentrations of 50 ng for 100 ng RNA template and 200 ng for 
500ng RNA template. The total volume of each samples containing RNA, hexameric 
primers and milliQH2O was 14 µl. The samples were heated to 70°C for 5 minutes to 
melt possible secondary structures within the templates. Then, the tubes were cooled 
on ice for 5 minutes. In the meantime a master mix was prepared. 
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Master Mix 
Compound 1x 
M-MLV RT 5x Reaction Buffer  5 µl 
10mM dNTP Mix 1.25 µl 
milliQ water 3.75 µl 
MLV Reverse Transcriptase (200U/µl) 1 µl 
 11 µl 
Per tube 11 µl of master mix were added to the initial volume of 14 µl resulting in a 
total sample volume of 25 µl. The reverse transcriptase was not added to the master 
mix for the duplicate samples (-RT controls). In order to allow the hexamer primers 
anneal to the templates, the samples were kept at room temperature for 10 minutes. 
Then, the tubes were transferred to 43°C for 50 minutes to perform the reverse 
transcription. Afterwards, the samples were kept at 70°C for 15 minutes to inactivate 
the enzyme. 
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4.2.10. Polymerase chain reaction (PCR) 
 
10 mM dNTP Mix 10 mM dATP 
 10 mM dCTP 
 10 mM dGTP 
 10 mM dTTP 
 
Two different polymerases were used for the PCR reactions. The PCR mix per 
reaction was as described in the following table. 
Compound 1x Compound 1x 
MilliQ Water Up to 25 µl MilliQ Water Up to 25 µl 
10 x Thermo Pol. 
Reaction buffer (NEB) 
2.5 µl 5 x green GoTaq reaction 
buffer (Promega) 
5 µl 
10 mM dNTPs Mix 0.5 µl 10 mM dNTPs 0.5 µl 
  25 mM MgCl2 1 µl 
Forward Primer (100 µM) 0.4 µl Forward Primer (100 µM) 0.25 µl 
Reverse Primer (100 µM) 0.4 µl Reverse Primer (100 µM) 0.25 µl 
NEB Taq Polymerase    
(5 U/µl) 
0.3 µl Promega GoTaq 
Polymerase (5 U/µl) 
0.125 µl 
 
The amount of cDNA used in the PCR reactions depended on the RNA concentration 
used in the reverse transcription beforehand. Thus, either 1 µl cDNA (500 ng RNA 
template in the RT) or 2 µl cDNA (100 ng RNA template in the RT) were used for the 
PCR reactions.  
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Cycling conditions 
95°C 2 minutes 
95°C 30 seconds 
Primer annealing temperature 30 seconds 
72°C 1 minute 
72°C 5 minutes 
4°C  storage 
 
 
Number of 
cycles 
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4.2.11. Detection of bantam miRNA using hairpin RT-PCR 
 
For detection of miRNAs, a special reverse transcription was performed with a stem-
loop hairpin primer. The method is based on an article published by Chen and co-
workers (Chen, 2005). In the study a so called TaqMan-based real-time quantification 
of miRNAs is described which was adapted to my purpose of miRNA detection (see 
figure 4.6.). The procedure includes two 
steps: stem-loop RT and PCR. The stem-
loop RT primers bind to the 3‟ end of miRNA 
molecules which are reverse transcribed with 
reverse transcriptase. The RT product is 
detected by PCR which includes a miRNA 
specific forward primer and a reverse primer 
binding in the hairpin sequence. 
 
 
( adapted from Chen, 2005) 
 
 
Figure 4.6.: Schematic description of stem-loop RT-PCR 
 
Hairpin primer (SD250): for bantam detection 
 
5‟ GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAATCAG 3‟ 
 
The hairpin primer was used at a final concentration of 0.06 pmol per µl sample. 
Reverse transcription was performed as follows: 
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Compound 1 x 
M-MLV RT Reaction buffer 5x 2.5 µl 
10 mM dNTP-Mix 0.63 µl 
Hairpin primer (diluted to 1 pmol/µl)  1 µl 
M-MLV Reverse Transcriptase 0.5 µl 
Template RNA x µl 
MilliQ H2O Fill up to 15 µl 
 
The template RNAs were used in a concentration of 600 - 700 ng/µl. 
The reaction conditions for the reverse transcription were 16°C for 30 minutes, 
followed by 42°C for 30 minutes and 85°C for 5 minutes. Then, samples were stored 
at 4°C. 
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Then a PCR was performed with a bantam specific forward primer and a reverse 
primer binding the stem-loop sequence. 
 
Compound 1x 
MilliQ Water Up to 25µl 
5 x green GoTaq reaction buffer 
(Promega) 
5 µl 
10 mM dNTPs 0.5 µl 
Forward Primer SD251 (100 µM) 0.17 µl (1.5 µM) 
Reverse Primer SD252 (100 µM) 0.38 µl (0.7 µM) 
GoTaq Polymerase (5 U/µl) 0.125 µl 
Template: cDNA from above 1.7 µl 
 
Cycling conditions 
95°C 10 minutes 
95°C 15 seconds 
60°C 1 minute 
 
40 cycles 
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4.2.12. Denaturing Polyacrylamide Gel: 15% PAGE/UREA 
 
15% PAGE/ 8M UREA (for 100ml solution) 
5 ml 20 x TBE 
37.5 ml 40 % Acrylamide/Bisacrylamide (AA/BA) 19:1 
48.1 g Urea 
 
The Urea was dissolved completely by stirring. 
 
In order to prepare a 2 mm thick denaturing PAA gel (24.5 cm x 19.5 cm) 50 ml PAA 
solution were prepared. Per 5 ml 15 % PAGE/UREA solution 25 µl 10 % APS and 2 
µl Temed were added and the gel was poured immediately and without air-bubbles 
using a syringe. In order to polymerize, the gel was kept for 1 hour at room 
temperature. Before loading the RT-PCR products were mixed with 5x DNA loading 
dye and heated to 95°C for 5 minutes. In order to determine the product size 10 µl of 
a 50Bp marker (NEB) were loaded. The gel was run for 1.5 hours at 200 Volt 
constant with 1x TBE buffer. Afterwards the gels were stained in a solution of 1x TBE 
containing 0.5 µg/ml Ethidium Bromide, at room temperature for 10 minutes.  
 
 
4.2.13. Protein Precipitation from sucrose fractions using TCA 
Protocol adapted from Luis Sanchez 
 
In order to precipitate the proteins from the sucrose fractions 1 volume of TCA-
solution was added to 4 volumes of sample. After vortexing, the samples were 
incubated at 4°C for 15 minutes. Then, the tubes were centrifuged for 10 minutes at 
16100 x g at 4°C. The supernatant was removed and the pellet was washed three 
times with 200 µl ice-cold acetone. Between the washing steps the samples were 
centrifuged for 5 minutes at 16100 x g at 4°C. The pellet was dried for a 10 seconds 
at 90°C with open lid. Afterwards, the pellet was resuspended in 20 µl of 2 x SDS 
loading dye. The samples were separated on SDS-PAGE gels followed by western 
blot analysis. 
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4.2.14. SDS-PAGE 
 
After assembly of the SDS-PAGE gel apparatus leak-proof and dry, the gel solutions 
were prepared. APS and Temed were added just before pouring since they induce 
polymerization of the gel. The separating gel was poured first followed by covering 
the top of the gel with ethanol or isopropanol to produce a flat and air bubble free 
surface. Upon gel polymerization (15-30 minutes depending on the gel size and 
thickness) ethanol/isopropanol was removed. The stacking gel was poured on top of 
the separating gel and the combs were inserted immediately. 
 
Gel sizes:  
 Small gels: 9.5 cm x 10 cm and 1 mm thick 
 Big gels: 14 cm x 16 cm and 1.5 mm thick 
 
Amounts calculated for two small 1 mm thick gels (9.5 cm x 10 cm) or one big 1.5 
mm thick gel (14 cm x 16 cm) 
 
After polymerization of the stacking gel, the combs were removed and the gels were 
fixed in the electrophoresis apparatus. GTS running buffer was applied covering the 
whole gel. Before loading, the protein samples (stored in 2 x SDS protein sample 
buffer) were heated 5 minutes to 95°C to ensure denaturation of the proteins. In 
Compounds Separating Gel 
7.5 % 
Separating Gel 
12 % 
Stacking Gel 
4 % 
ddH2O 5.5 ml 4.29 ml 3.77 ml 
1.5 M Tris/HCl pH 8.2 2.5 ml 2.5 ml  
1 M Tris/HCl pH 6.8   625 µl 
10 % w/v SDS 100 µl 100 µl 50 µl 
40 % PAA/BAA 37:1 1.875 ml 3 ml 500 µl 
10 % w/v APS 100 µl 100 µl 50 µl 
Temed 10 µl 10 µl 5 µl 
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order to determine the molecular weight of the analyzed proteins prestained protein 
ladder (NEB #P7703) was loaded (5 µl for the small gels and 10 µl for the big gels). 
The small gels ran at 120 Volt for 1.5-2 hours, the big ones at 150-170 Volts for ~3 
hours. 
 
4.2.15. Western Blotting and Immunostaining 
 
A Wet/Tank Blotting System (Bio-Rad) was used for western. First, the separating gel 
from SDS-PAGE, Whatman papers and fiber pads were equilibrated in 4°C cold 
transfer buffer. The PVDF membrane was activated in methanol and equilibrated in 
transfer buffer as well. If a nitrocellulose membrane was used it was equilibrated only 
in transfer buffer. The blotting sandwich was assembled in transfer buffer and without 
air bubbles as follows: 
 
Cathode (-) 
Fiber Pad 
Three Whatman papers 
Separating gel 
Membrane 
Three Whatman papers 
Fiber Pad 
Anode (+) 
 
The blotting was performed at 4°C with ice-buckets at 100 Volt for 1.5 hours. 
 
For immunostaining the antibodies listed in section 4.1.3 were used. After blotting, 
the membranes were blocked usually overnight in 1 x PBS-Tween containing 5 % of 
milk powder. Then, the membranes were rinsed with 1 x PBS-Tween and incubated 
in primary antibody for 1 hour at 4°C on a shaker. Next, the membranes were 
washed 3 times with 1 x PBS-Tween for 10 minutes at room temperature on a 
shaker. Then, the membrane was incubated in secondary antibody for 1 hour at 4°C 
on a shaker. The membrane was washed again three times with 1 x PBS-Tween for 
10 minutes at room temperature on a shaker. The secondary antibodies I used were 
linked to an enzyme termed horseradish peroxidase (HRP) allowing an ECL 
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(enhanced chemiluminescence) detection. Thus, to detect the HRP signal, the 
detection solution was supplemented with H2O2 (see section 4.1.6.8) and applied 
onto the membrane for 2 minutes. The luminol from the solution is the substrate for 
the HRP and leads to light emission. The signals were captured by autoradiography 
films which were developed in a CURIX 60 machine (AGFA). 
 
4.2.16. Agarose gel electrophoresis 
 
In order to detect PCR-products or restriction digest products 1-2% TAE agarose 
gels were used. The agarose was fully dissolved in 1 x TAE by cooking the solution 
in the microwave. When the solution cooled down (to around 60°C) Ethidium 
Bromide was added to a final concentration of 0.5 µg/ml and the gel was poured 
immediately into a gel tray. The addition of Ethidium Bromide allows visualizing the 
product (DNA) in the UV light later on. The samples to analyze were mixed with 5 x 
DNA loading dye, loaded and the gels ran at 110 volt 1 x TAE (running buffer). The 
gel pictures were made in an UV light/ camera system. For semi-quantitative 
analysis, the 2 % agarose gels were scanned in the Typhoon TRIO (see section 
6.2.3.3). 
 
4.2.17. Ribosome Pelleting 
 
In order to perform ribosome pelleting, S2 cells were transfected with the plasmids 
described in 4.1.5 and harvested 3 days after transfection. One well of a six-well 
plate was used for one pelleting experiment. First, the cells were incubated with 0.1 
mg/ml cycloheximide for 20 minutes at room temperature to stall the ribosomes. 
Then, the cells were collected and centrifuged at 188 x g for 5 minutes at 4°C. The 
supernatant was removed and the pellet was washed once with 1x PBS 
supplemented with 0.1 mg/ml cycloheximide. After a short spin (8 seconds), the 
supernatant was removed again and the pellet was resuspended in 250 µl isotonic 
lysis buffer (same as for polysome gradients see section 4.2.5). The S2 cells were 
lysed on ice for 10 minutes. Afterwards, the lysate was cleared from cell debris an 
unlysed cells by centrifugation at 16100 x g for 10 minutes at 4°C. The sucrose 
cushion was prepared in 2 ml Polycarbonate thickwall tubes without cap (Beckman). 
The tubes were filled with 600 µl sucrose solution (see section 4.1.6.10) and 200 µl of 
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lysate was carefully layered on top of the cushion. An input sample was kept 
beforehand and stored in 2 x SDS protein sample buffer. The tubes were balanced 
and transferred in a pre-cooled TLA 100.2 rotor. For centrifugation an Optima TLX 
Ultracentrifuge (Beckman) was used. The samples were centrifuged for 40 minutes 
at 75000rpm at 4°C. Afterwards the supernatant was carefully removed and the pellet 
was dissolved in 25 µl of 2 x SDS protein sample buffer. Then, the samples were 
separated on SDS-PAGE gels and examined by western blot analysis. 
 
4.2.18. Co-Immunoprecipitation 
 
Lysis Buffer  Washing Buffer 
Final concentration 
20 mM Tris/HCl pH 7.5 
150 mM NH4Cl 
5 mM MgCl2 
0.5 % w/v NP40 
2 mM DTT 
0.01 mg/ml heparin 
1 x Complete PI EDTA-free 
0.5 U/µl RiboLock 
1 mg/ml Cycloheximide 
MilliQ water 
 
The co-immunoprecipitation experiments were performed different from standard 
protocols since it was intended to keep the polysomes intact and the procedure 
RNase-free. Therefore, cycloheximide and MgCl2 were necessary in the protocol. 
 
Cell harvest and cycloheximide incubation 
S2 cells were transfected with the plasmids described in section 4.1.5 and harvested 
after 3 days. One well S2 cells of a six-well plate was used for one co-IP experiment. 
First, the cells were incubated with 0.1 mg/ml cycloheximide for 20 minutes at room 
temperature to keep the polysomes intact. This was followed by centrifugation at 188 
x g for 5 minutes at 4°C. The supernatant was removed and the pellet was washed 
with 1 x PBS supplemented with 0.1 mg/ml cycloheximide.  
Final concentration 
0.1 mg/ml cycloheximide 
0.3 % w/v Igepal 
5 mM MgCl2 
 MilliQ water 
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Cell lysis 
In order to lyse the cells, the pellet was dissolved in 200 µl lysis buffer (described 
above). Lysis was performed on ice for 15 minutes. Then, the lysate was cleared by 
centrifugation at 16100 x g for 15 minutes at 4°C.  
 
Preparing the beads 
Sepharose-beads covalently crosslinked to anti-HA-antibodies (see section 4.1.6.11.) 
were used for immunoprecipitations. Around 20-30µl of 50% slurry beads (~10-15µl 
real beads) were transferred into eppendorf tubes and pre-cooled. It was checked by 
eye whether the amount of beads taken was equal for all samples.  
 
Bead Binding 
From the lysate 20 µl of input was kept and diluted with 20 µl 2x SDS loading dye. 
The remaining lysate was diluted to 500 µl with Lysis Buffer and transferred onto the 
pre-cooled beads. Beads and lysate were rotated overhead at 4°C for 2 hours. The 
beads were collected by centrifugation at 400 x g for 2 minutes at 4°C.  
 
Washing the beads 
Then, the supernatant was removed and the beads were washed three times with 
300 µl Washing Buffer and once with 300 µl 1x PBS (RNase-free) supplemented with 
0.1 mg/ml cycloheximide. Between the washing steps the beads were collected by 
centrifugation at 400 x g for 2 minutes at 4°C. After the last washing step, the 
supernatant was removed very carefully and 50 µl of 2 x SDS protein sample buffer 
were added to the beads. The input and co-IP samples were heated to 90°C for 2 
minutes. Then the samples were vortexed for 15-30 seconds and incubated again for 
30 seconds at 90°C. Then the samples were centrifuged at 16100 x g for 2 minutes, 
separated on SDS-PAGE gels and examined by western blot analysis. 2.5 % of input 
and 36 % of the immunoprecipitate were loaded on the gel in all experiments. 
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5. Aims of the Thesis 
 
The goal of this project was to identify novel microRNA targets which are 
translationally repressed without being degraded. The identification novel miRNA 
targets will provide new examples for translationally repressed but stable mRNAs. 
This opens up the possibilty of functional studies and will contribute to understand 
the general importance of stable microRNA targets in a cell. The idea was to use 
polysome gradient analysis and to fractionate mRNAs of Drosophila S2 cells. Non-
repressed mRNA targets should be found in the polysomal fractions of gradient, 
since they are actively translated, while repressed mRNA targets should migrate in 
the light/RNP fractions. As reporters for repressed mRNA targets, either known 
endogenous or artificial firefly luciferase sensors were tested.  
Since miRNAs and repressed miRNA targets were found to co-migrate with the 
polysomes, I wanted to test whether proteins involved in the miRNA-mediated 
response are co-migrating with the polysomes in a density gradient as well.  
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6. Results 
 
Background of this study 
 
Drosophila Schneiders 2 cell line 
Drosophila cells are an amendable system due to low redundancy of protein factors, 
e.g. two AGO proteins in Drosophila cells and four in mammals (reviewed in Joshua-
Tor, 2010) or one GW182 in Drosophila and three paralogs in mammals (reviewed in 
Tritschler, 2010;). 
The Drosophila S2 cell line origin from Drosophila embryos in a late (20-24h) stage 
(Schneider, 1972). The cells show mesodermal characteristics, are roughly spherical 
and have 15-20µm in diameter (Rogers, 2008). S2 cells are a well established and 
an easy to handle in culture system.  
 
The putative endogenous miRNA targets hid and vha68-1 
The term microRNA target refers to an mRNA which is regulated by a particular 
miRNA on the translational level. A miRNA target has binding sites for one or more 
miRNAs mostly in its 3‟UTR (see section 3.3).  
The endogenous miRNA targets analyzed in the following experiments have been 
extensively studied in D.melanogaster. The proapoptotic gene head involution 
defective (hid) is a target of the microRNA bantam in D.melanogaster (Brennecke, 
2003; Nahvi, 2009). Another microRNA target analyzed was vha68-1. In D. 
melanogster, vha68-1 belongs to the V-ATPase gene family (Allan, 2005). Vha68-1 
has two miR9b binding sites in its 3‟UTR (Stark, 2005; Rehwinkel, 2005).  
 
Nerfin-1 
The nerfin-1 gene of Drosophila melanogaster encodes a transcription factor specific 
for the nervous system, which harbors 21 predicted binding sites for 18 different 
miRNAs (e.g. miR9b) in its 3‟UTR (Stark, 2005; Kuzin, 2007;). Kuzin and co-workers 
(Kuzin, 2007) analyzed the functional significance of miRNA binding sites in the 
nerfin-1 3‟UTR in vivo. They demonstrated that not a single miRNA-binding site is 
sufficient to repress endogenous nerfin-1 but multiple miRNAs are required in this 
case for post-transcriptional gene silencing.  
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Polysome analysis using sucrose density gradients 
During the translation of an mRNA (see section 3.4.1.), a small (40S) associates with 
a big (60S) ribosomal subunit on the mRNA to form a functional 80S ribosome 
(monosome). As the ribosome moves along the mRNA and thereby elongates the 
polypeptide chain other ribosomes can start translation on the same mRNA forming 
polyribosomes (polysomes). A polysome complex contains two or more ribosomes 
associated to the same mRNA determining the mass of such a complex. Actively 
translating mRNAs are thought to be in polysomes while translationally repressed 
mRNAs are thought to be in RNP (ribonucleoprotein) or monosome complexes. In 
polysome analysis, cell lysates are prepared and separated on sucrose density 
gradients. Particles separate in the sucrose gradient depending on their relative 
molecular weight. The sucrose gradient is fractionated while the OD 254 is recorded 
(figure 6.1.). The majority of the OD254 signal is derived from nucleic acids such as 
ribosomel RNA (rRNA) present in the different parts of the gradient. The peaks at 
fractions with low sucrose concentration correspond to the sedimentation of RNPs 
(ribonucleoproteins) followed by the ribosomal subunits 40S and 60S, the 80S 
ribosomes (monosomes), and mRNAs associated to two or more ribosomes 
(polysomes).  
In previous studies polysome gradients have been used extensively to analyze 
miRNA mediated response (Nottrott, 2006; Pillai, 2005; Ding, 2009;Olsen, 1999). 
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Figure 6.1: Polysome Profile from Drosophila S2 cell lysate 
Lysate of S2 cells were separated on a density gradient 15-45 % sucrose. The lines on top of 
the figure represent RNPs, the 80S peak (monosomes) and polyribosome fractions. On the 
bottom of the figure is shown were the translated mRNAs and translationally repressed 
miRNA targets were anticipated in this study. The optical density at 254 nm (OD 254) was 
monitored using a UA-6 UV/VIS detector during fractionation. 
 
 
As indicated in figure 6.1, I anticipated that mRNAs repressed by miRNAs are miRNP 
fractions and not associated to polysomes in sucrose density gradients. On the other 
hand, non-repressed target mRNAs, which are actively translated I anticipated mainly 
in the polysome fractions of a sucrose density gradient. 
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6.1. Analysis of endogenous microRNA targets hid and 
vha68-1 in polysome gradients 
 
In initial experiments I wanted to address the question, how putative endogenous 
miRNA targets and actively translated mRNAs are migrating in polysome gradients. 
Thus, Drosophila S2 cell lysates were separated on a sucrose density gradient. The 
gradient was fractionated under continuous measurement of the OD 254 (spectrum 
see figure 6.2 A). The RNA was isolated from the collected fractions and reverse 
transcribed with random hexamer primers. That results in the reverse transcription of 
all RNAs present in the sample into complementary DNA (cDNA). The cDNA was 
used for PCR analysis amplifying any mRNA of interest. In order to exclude the 
possibility that DNA contaminations are amplified during the PCR, for every sample a 
control lacking reverse transcriptase was done in the cDNA synthesis step. Ideally, 
there are no DNA contaminations and therefore no product should be amplified 
during PCR analysis. 
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Figure 6.2: Polysome Gradient analysis of Drosophila S2 cell lysate 
(A) S2 cell lysate separated on a 15-45 % sucrose gradient. OD 254nm was monitored. 
Numbers on the spectrum indicate the fraction number. 
(B) RNA from the fractions collected in (A) was isolated, RT-PCR analysis for RP49, hid, 
vha68-1 was performed and the products visualized on a 1 % agarose TAE gel.The bantam 
miRNA was detected by hairpin RT-PCR and the product was visualized on a 15 % 
polyacrlyamid/ 8 M urea gel. Fraction numbers and RNP, 80S, polyribosomes are indicated 
above. Samples are shown with (+ ) and without ( – ) reverse transcriptase.  
 
The RT-PCR analysis of the miRNA targets vha68-1 and hid are shown in figure 
6.2.B. Both, the hid and the vha68-1 RT-PCR product peak in the polysomal fractions 
(figure 6.2.B fractions # 15, 18, 22;). Furthermore, RT-PCR analysis was performed 
to detect the mRNA of the ribosomal protein RP49 as an example for an actively 
translated mRNA. The RT-PCR product of RP49 is enriched in the polysomal 
fractions (figure 6.2.B fractions # 13, 15, 18, 22;). 
The distribution of the miRNA bantam targeting hid mRNA was analyzed by stem-
loop RT-PCR (see section 4.2.11) and analyzed on a denaturing polyacrylamide gel 
(figure 6.2.B.). bantam distributes equally throughout the sucrose gradient.  
The experiment was performed twice with similar results. 
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If the putative miRNA targets hid and vha68-1 were indeed repressed in these 
Drosophila S2 cells, their accumulation in the polysomal fractions is surprising. 
However, due to the lack of antibodies against HID or VHA68-1, I could not examine 
the status of repression at the protein level. Thus, the only conclusion that could be 
made was that none of these endogenous miRNA targets can be used to facilitate 
the identification of novel repressed miRNA targets. 
Therefore, I tested artificial Fluc-nerfin mRNA sensors in the next experiments which 
allow to determine the efficiency of the miRNA repression. 
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6.2. Dual-luciferase reporter system for polysome gradient 
analysis 
 
6.2.1 Overview: Luciferase sensors and bioassays 
 
Bioassays using luciferase sensors 
Bioluminescent assays rely on luciferase enzymes which catalyze the oxidation of 
their respective substrate. The reaction results in the emission of photons which are 
measured (Thorne, 2010). Luciferase assays have a higher sensitivity than for 
example assays using fluorescence (Thorne, 2010).  
 
Biochemical reactions 
Two commonly used luciferase sensors are the Firefly and the Renilla luciferase 
derived from the firefly Photinus pyralis and the sea pansy Renilla reniformis. 
The Firefly luciferase enzyme oxidizes D-luciferin to oxyluciferin under ATP 
consumption and light emission (figure 6.3.A). The Renilla luciferase catalyzes the 
oxidative decarboxylation of the coelenterazine to coelenteramide with the emission 
of blue light (figure 6.3.B). 
 
(Held, 2006) 
Figure 6.3.: Bioluminescent reactions catalyzed by Firefly and Renilla luciferase 
(A) Firefly luciferase catalyses the oxidation of Luciferin to oxyluciferin under ATP 
consumption. This yields in the emission of light at 560 nm. (B) Renilla luciferase catalyses 
the oxidation of coelenterazine to coelenteramide and thereby light at 480 nm is emitted. 
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Dual luciferase assays 
In dual luciferase assays, two luciferase enzymes are measured in the same 
experiment. This is possible because the Firefly luciferase can be quenched before 
substrates for the Renilla luciferase are added. One luciferase activity is used to 
examine the target biology while the other one is used for assay normalization. 
Normalization is important, since differences in cell number and transfection 
efficiency have to be considered in order to compare different experiments (Thorne, 
2010).  
 
6.2.2. Reporter constructs used in dual luciferase assays 
 
The Firefly luciferase nerfin-1 reporter (Fluc-Nerfin) encodes a firefly luciferase gene 
fused to the 3‟UTR of the D. melanogaster gene nerfin-1. Amongst others the nerfin-
1 3‟UTR harbors binding sites for the miRNA miR9b. The Fluc –Nerfin reporter was 
transiently transfected into Drosophila S2 cells with a plasmid expressing the Renilla 
luciferase and either a miR9b-expressing or an empty vector plasmid (figure 6.4.). 
Consequently, the Fluc-Nerfin reporter can be monitored when its repressive miRNA 
miR9b is present or not. The co-transfection of the empty vector instead of the 
miR9b-plasmid is necessary since I wanted to exclude effects coming from the vector 
only. The Renilla luciferase reporter (Rluc) serves as a transfection control. All Firefly 
luciferase signals were normalized to Renilla luciferase signals resulting in relative 
Fluc/Rluc values.  
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Figure 6.4: Reporter constructs for Dual Luciferase Assays 
Representation of the Firefly luciferase reporter fused to the Nerfin-1 3‟UTR, containing 
binding sites for miR9b. Renilla luciferase was co-transfected in each experiment as a 
transfection control, to normalize the Fluc-nerfin luciferase signals. Further, a plasmid 
encoding the miR9b-gene or the empty vector was co-transfected. 
 
The Fluc-activity of Fluc-Nerfin was measured in a luminometer. The Firefly 
luciferase substrate and the Renilla luciferase substrate were added sequentially. In 
my experiments, the co-expression of miR9b resulted in a 70-90% repression of the 
Firefly luciferase activity compared to the empty-vector control (see e.g. figure 6.5. 
and 6.7.) 
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6.2.3. Dual-luciferase reporters analyzed in polysome gradients 
 
In the following experiment I wanted to demonstrate the repression of the Fluc-Nerfin 
reporter by the miRNA miR9b. As described in the previous section, I co-transfected 
S2 cells with plasmids expressing Fluc-Nerfin, Rluc and miR9b or the empty plasmid. 
The cells were harvested 3 days after transfection. In order to measure the miR9b-
mediated repression on protein level I assayed the Firefly and the Renilla luciferase 
activity. Transfected S2 cells were lysed in Passive Lysis Buffer (Promega) and the 
activity of the luciferases was measured in a luminometer by sequentially adding their 
substrates. The normalized Fluc/Rluc values are shown in figure 6.5. 
 
 
Figure 6.5: miR9b-mediated repression of Fluc-Nerfin reporter 
Samples on the x-axis: miR9b indicates S2 cells transfected with Fluc-Nerfin, Rluc and 
miR9b, empty indicates S2 cells transfected with Fluc, Rluc and empty plasmid. Cells were 
lysed 3 days after transfection in Passive Lysis buffer. Luciferase activities were measured in 
dual luciferase assays using a luminometer. The luciferase values are plotted on the y-axis: 
Firefly luciferase values are normalized to Renilla luciferase values resulting in relative 
Fluc/Rluc activities. The empty Fluc/Rluc value was set to 1 and miR9b was calculated 
relative to it. 
 
The repression of the Firefly luciferase in the presence of miR9b was around 90% 
compared to the empty control (figure 6.5.). Thus, the Fluc-Nerfin reporter responds 
significantly to miR9b and the repression works. 
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In the following experiment I wanted to show how the repressed and the unrepressed 
Fluc-Nerfin reporter are migrating in a polysome gradient. Further, I wanted to 
analyze how vha68-1, the endogenous target of miR9b, sediments in a polysome 
profile. RP49 and Rluc were analyzed as examples for non-repressed and actively 
translated mRNAs. 
S2 cells co-expressing Fluc-Nerfin, Rluc and miR9b or empty vector were lysed and 
separated on a 15-45 % sucrose density gradient. The gradient was fractionated 
while the OD 254 was measured (spectra figure 6.6. A and C). The RNA was isolated 
from the collected fractions and reverse transcribed using random hexamer primers. 
That results in the transcription of all RNAs present in the sample into 
complementary DNA (cDNA). The cDNA was used for PCR analysis on the target 
genes. In order to exclude the possibility that DNA contaminations are amplified in 
the PCR reaction, a control was done for each sample without adding reverse 
transcriptase in the cDNA synthesis step. The PCR-products were separated on 
agarose TAE gels and are depicted in figure 6.6. B and D. 
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+ miR9b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6: Polysome Gradient analysis of S2 cell lysate with Fluc-Nerfin reporter 
(A), (C) S2 cells were co-transfected with plasmids expressing Fluc-Nerfin and Rluc reporter 
and a plasmid encoding miR9b (+mir9b) or the corresponding empty plasmid (-miR9b). 3 
days after transfection cells were lysed and separated on a 15-45% sucrose gradient. OD254 
was monitored. Numbers on the spectrum indicate the fractions. 
(B), (D) RNA from the collected fractions (numbers indicated above) was isolated. RT-PCR 
analysis for Fluc-Nerfin (Fluc), Renilla luciferase (Rluc) and endogenous vha68-1 was 
performed. RNPs, 80S and polysomes are indicated above. Samples are shown with (+ ) and 
without ( – ) reverse transcriptase.  
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The non-targeted Fluc-Nerfin reporter mRNA migrated all over the gradient (figure 
6.6.B Fluc fractions # 3, 5, 7, 9, 11, 13, 15, 17, 19). The reporter is actively 
translated, which is reflected also in the high Firefly luciferase activity (figure 6.5. 
empty). The endogenous miR9b target vha68-1 is detected mostly in polysomal 
fractions (figure 6.6.B vha68-1 fractions # 11, 13, 15, 17, 19, 21). This is in 
agreement with previous results on the vha68-1 distribution in a polysome gradient of 
S2 cell lysates (figure 6.2 vha68-1). 
Figure 6.6 D shows Fluc-Nerfin and endogenous vha68-1 upon expression of miR9b. 
Both Fluc-Nerfin and vha68-1 shift to the RNP/80S fractions (figure 6.6.D Fluc and 
vha68-1 fractions # 2, 4, 6, 8, 10). In addition vha68-1 is detected in the polysomal 
fractions of the gradient (figure 6.6.D vha68-1 fractions # 14, 16, 18, 20, 22, 24). In 
this experiment Fluc-Nerfin and vha68-1 shift quite significantly to the RNP/80S 
fractions upon miR9b-mediated repression. As anticipated, Rluc and RP49 are 
distributed all over the gradients regardless of the presence of miR9b (figure 6.6. B/D 
Rluc all fraction #).  
 
The results of this initial experiment were promising. The miR9b repression of Fluc-
Nerfin was significant at the protein level. In polysome analysis Fluc-Nerfin and 
endogenous vha68-1 shifted into the RNP/80S fractions upon miR9b repression. In 
contrast, the Rluc reporter and endogenous RP49 are actively translated in both sets 
and not affected by miR9b. I repeated this experiment twice and the outcome is 
depicted in the following figures. 
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In the following experiments I investigated the consistency of the Fluc-Nerfin 
migration in a polysome gradient with and without miR9b expression. 
The experiment was performed as the previous one (figure 6.5. and 6.6.). S2 cells 
co-expressing Fluc-Nerfin, Rluc and either miR9b or empty vector were lysed and the 
luciferase activities were measured. The normalized Fluc/Rluc values are shown in 
figure 6.7. In one experiment the Firefly luciferase is repressed up to 80% in the 
presence of miR9b (figure 6.7.A). The other experiment shows a Firefly luciferase 
repression of 70% (figure 6.7.B). 
 
 
 
Figure 6.7: miR9b-mediated repression of Fluc-Nerfin reporter 
Samples on the x-axis: miR9b indicates S2 cells transfected with Fluc-Nerfin, Rluc and 
miR9b, empty indicates S2 cells transfected with Fluc-Nerfin, Rluc and empty plasmid. Cells 
were lysed 3 days after transfection in passive lysis buffer. Luciferase activities were 
measured in dual luciferase assays using the luminometer. The luciferase values are 
depicted on the y-axis: Firefly luciferase values are normalized to Renilla luciferase values 
resulting in relative Fluc/Rluc activities. The empty Fluc/Rluc value was set to 1 and miR9b 
was calculated relative to it. 
(A) miR9b-mediated repression of Fluc-Nerfin reporter of experiment shown in figure 6.9 
(B) miR9b-mediated repression of Fluc-Nerfin reporter of experiment shown in figure 6.10 
 
In both experiments the miR9b-mediated repression of the Firefly luciferase activity 
was significant. 
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Both of the polysome gradient analyses were performed as previously described. As 
in the previous experiment (figure 6.6) without expression of miR9b, all mRNAs 
tested, the non-repressed Fluc-Nerfin, the endogenous miRNA-target vha68-1 (figure 
6.8.B, 6.9.B Fluc and vha68-1 fraction # 5, 7, 9, 11, 13, 15, 17, 19, 21, 23) and the 
controls, Rluc and RP49 are distributed throughout the gradient (figure 6.8.B, 6.9.B 
Rluc and RP49 fraction # 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23). 
In contrast to the initial experiment, no shift of Fluc-Nerfin or vha68-1 into the 
RNP/80S fractions of the gradient was observed upon expression of miR9b. The 
reporter and the endogenous miR9b target are detected in almost all fractions of the 
gradient (figure 6.8.D, 6.9.D. Fluc and vha68-1 fraction # 3, 5, 7, 9, 11, 13, 15, 17, 
19, 21, 23). Again, Rluc and RP49 are distributed throughout the gradient (figure 
6.8.D, 6.9.D. Rluc and RP49 fraction # 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23). 
In the initial polysome analysis (figure 6.6.) there was a shift of both targets, Fluc-
Nerfin and endogenous vha68-1, into the RNP/80S fractions upon miR9b expression. 
Therefore, the results of the first experiment were not reproducible. I could not clarify 
the reasons for these contradictory findings in three almost identical experiments. 
Nevertheless, I wanted to make sure that I also detect a minor shift which might not 
be visible by eye and performed a semi-quantitative analysis of the PCR products 
from figure 6.8.  
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Figure 6.8: Polysome Gradient analysis of S2 cell lysate with Fluc-Nerfin reporter – repeat #1 
(A), (C) S2 cells were co-transfected with plasmids expressing Fluc-Nerfin and Rluc reporter and a plasmid encoding miR9b (+mir9b) or the 
corresponding empty plasmid (-miR9b). 3 days after transfection cells were lysed and separated on a 15-45% sucrose gradient. OD254 was 
monitored. Numbers on the spectrum indicate the fractions. 
(B), (D) RNA from the collected fractions (numbers indicated above) was isolated. RT-PCR analysis for Fluc-Nerfin (Fluc), Renilla luciferase (Rluc) 
and endogenous vha68-1 was performed. RNPs, 80S and polysomes are indicated above. Samples are shown with (+ ) and without ( – ) reverse 
transcriptase
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Figure 6.9: Polysome Gradient analysis of S2 cell lysate with Fluc-Nerfin reporter – repeat #2 
(A), (C) S2 cells were co-transfected with plasmids expressing Fluc-Nerfin and Rluc reporter and a plasmid encoding miR9b (+mir9b) or the 
corresponding empty plasmid (-miR9b). 3 days after transfection cells were lysed and separated on a 15-45% sucrose gradient. OD254 was 
monitored. Numbers on the spectrum indicate the fractions. 
(B), (D) RNA from the collected fractions (numbers indicated above) was isolated. RT-PCR analysis for Fluc-Nerfin (Fluc), Renilla luciferase (Rluc) 
and endogenous vha68-1 was performed. RNPs, 80S and polysomes are indicated above. Samples are shown with (+ ) and without ( – ) reverse 
transcriptase 
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6.2.3.3. Semi-quantitation of Fluc-Nerfin, Rluc, vha68-1 and RP49 mRNA levels in 
polysome gradients 
 
The aim of this experiment was to perform a semi-quantitative estimation of the 
ethidium bromide signals depicted in figure 6.8 B and D. The RT-PCR-products were 
analyzed on 2 % agarose TAE gels. The gels were scanned with the Typhoon TRIO 
using a green laser scan (535 nm). The software used for analysis was ImageQuant 
5.2 and Microsoft Excel 2003. The emission at 610 nm was measured and the values 
are given in arbitrary units (figure 6.10.). Arbitrary units are a relative unit of 
measurement which allows (in this case) to calculate the ratio of signal-intensity to 
total signal.  
 
 
Figure 6.10.: Semi-quantification of Fluc-Nerfin, Rluc, vha68-1, RP49 in a gradient +/- 
miR9b 
(A), (B), (C), (D); 2% agarose-gels (shown in figure 6.8.) were scanned with the Typhoon 
TRIO using a green laser scan (excitation 535 nm). The arbitrary units (Arb. Units) refer to 
the emission at 610 nm. The ratio of intensity of the ethidium bromide signal normalized to 
the total amount of signal was calculated (normalized) and plotted in the y-axis. The values 
on x-axis represent the number of the fraction.  
Red lines show the experiment with Fluc-Nerfin, Rluc and miR9b.  
Blue lines show the experiment with Fluc-Nerfin, Rluc and empty plasmid. 
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The RT-PCR products of the Renilla luciferase (Rluc) and RP49 were equally 
distributed over the gradient since their expression is not affected by miR9b (figure 
6.10. C and D). However, there are also no significant differences in the distribution 
of Fluc-Nerfin and vha68-1 with or without miR9b (figure 6.10.A and B). 
Thus, the outcome fully reflects the visual agarose-gel pictures from figure 6.8 and 
confirms that there is no shift of Fluc-Nerfin or vha68-1 into the RNP/80S fraction 
upon their repression.  
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Brief conclusion  
It was demonstrated that the predicted miRNA targets for Drosophila melanogaster 
hid and vha68-1 are migrating with the polyribosomes in sucrose density analysis of 
Drosophila S2 cell lysates. However, I did not confirm that hid and vha68-1 are 
indeed repressed in the S2 cells I used for my experiments. Furthermore, I performed 
polysome analysis of S2 cell lysates co-expressing a Fluc-Nerfin reporter and its 
targeting miRNA miR9b. I demonstrated that only in one of three experiments the 
repressed Fluc-Nerfin reporter is shifting to the RNP/80S fractions compared to the 
non-repressed reporter. In two of the three experiments the repressed Fluc-Nerfin 
reporter is distributed all over the gradient, similar to the non-repressed reporter. 
Therefore, these initial experiments using Fluc-Nerfin targeted or not by miR9b could 
not be used as a “tracer” to follow endogenous mRNA targets in polysome analysis. 
The next step would have been a knockdown of AGO1 (the main miRISC 
component) in S2 cells co-expressing the Fluc-Nerfin reporter plus miR9b. In case of 
an obvious shift of the Fluc-Nerfin from the RNP fractions into the polysomes, finding 
new miRNA targets by microarray analysis would have been a possibility. I tried to 
knockdown AGO1 in S2 cells using dsRNA soaking, but I was unsuccessful and 
obtained only very low knockdown efficiency. Therefore, I could not test whether an 
AGO1 knockdown would have led to significant differences in the polysome analysis 
compared to control cells.  
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6.3. Exploring the proteins involved in miRNA-mediated 
silencing 
 
In the previous experiments of this study I demonstrated that known endogenous 
microRNA targets, the miRNA bantam and the repressed Fluc-Nerfin reporter mRNA 
are migrating with polysomes in a sucrose density gradient of Drosophila S2 cell 
lysates. Hence, I was wondering if the proteins which are involved in miRNA-
mediated silencing do co-sediment with polysomes as well. 
 
 
Figure 6.11.: Scheme of miRNA mediated repression 
 
Before I describe the experiments, I briefly summarize our working model for miRNA-
mediated degradation (figure 6.11.) since several of the involved protein factors were 
analyzed. AGO1 is loaded with the respective miRNA into the miRISC complex and 
binds mostly to the 3‟untranslated region (3‟UTR) of the target mRNA. GW182 is the 
main interaction partner of AGO1 (Rehwinkel, 2005; Behm-Ansmant, 2006). The 
deadenylation of the target mRNA is initiated by the CCR4-NOT deadenylase 
complex and its accessory protein CAF1. Then, the 5‟cap of the mRNA is removed 
by the decapping enzyme (DCP2) which acts in a complex with several decapping 
activators (DCP1, EDC3, Me31B, HPat, Ge-1). After deadenylation and decapping, 
the target mRNA is susceptible to 5‟3‟ degradation through the exonuclease XRN1 
(reviewed in Garneau, 2007). Since bulk mRNA degradation in yeast can be co-
translational (Hu, 2009) we were wondering whether miRNA-mediated degradation 
could also take place to some extent on actively translation ribosomes. 
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Thus, I have analyzed tagged AGO1, GW182 and HPat by polysome analysis. 
Furthermore, I assayed Me31B, DCP1, CCR4, HPat, AGO1, GW182 in ribosome 
pelleting experiments. 
 
6.3.1 Migration of AGO1, GW182 and HPat in polysome gradients 
 
In order to analyse the distribution of AGO1, GW182 and HPat in polysome 
gradients, these proteins were stably expressed in Drosophila S2 cells as TAP-
tagged versions. The tandem affinity purification (TAP) tag is N-terminally fused to 
the proteins of interest. The tag consists of the immunglobulin binding domains of 
protein A and a calmodulin binding peptide separated by a tobacco etch virus (TEV) 
protease cleavage site (figure 6.12.) 
 
 
Figure 6.12.: N-terminal TAP tag  
The tag harbors two IgG binding domains of Staphylococcus aureus protein A (ProtA), an 
intervening tobacco etch virus (TEV) protease cleavage site and a calmodulin binding 
peptide (CBP).  
 
Generally, this tag is used to purify macromolecular complexes which can then be 
used in multiple applications (Puig, 2001). In my experiments the TAP-tag was used 
for detecting the protein of interest. 
I made lysates of each stable cell line in the logarithmic growth phase and separated 
them on a sucrose density gradient. Fractions were collected from the gradient under 
continous measurement of the OD 254 nm (spectra see figure 6.13. A, D, G). First, I 
separated 2 % of each collected sucrose fraction on a 7.5 % SDS-PAGE gel and 
analyzed it then by western blot analysis. Secondly, I precipitated the proteins from 
each fraction with Trichloracetic acid (TCA). Again, the precipitated proteins were 
separated on 7.5 % SDS-PAGE gels and analyzed by western blot analysis, using 
polyclonal anti-c-myc antibody. This antibody could be used for the experiments 
since the protein A of the TAP-tag (figure 6.12.) is binding the constant heavy chain 
(Fc-region) of immunglobulins. Consequently, any antibody is binding to protein A 
regardless from its variabel region and thereby gives a signal for detection. 
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Figure 6.13.: Tagged AGO1, HPat and GW182 in polysome analysis 
Polysome analysis performed in Drosophila S2 cells stably expressing TAP-tagged AGO1 (A), GW182 (D) or HPat (G). Numbers on the spectra 
indicate the fractions collected. 
(B), (E), (H) Western analysis from indicated fractions of the gradients. 2 % of each fraction was loaded. Lines on top of the figure indicate if 
fractions belong to RNPs, 80S or polysomes. Western blot analysis was performed using polyclonal anti-c-myc antibody. 
(C), (F), (I) Western analysis of TCA-precipitated proteins from indicated fractions of the gradients. Western blot analysis was performed using 
polyclonal anti-c-myc antibody. Input (IN) represents 0.05 % of total lysate for TAP-GW182 and 1.3 % of total lysate for TAP-AGO1 and TAP-HPat 
before loading onto the gradient. 
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In western blot analysis of the sucrose fractions without protein precipitation, HPat is 
detected weakly in the polysomes (figure 6.13.H fraction # 4-17). In contrast, AGO1 
(figure 6.13.B fraction # 4-6) and GW182 (figure 6.13.F fraction # 4-8) are not 
detected in the polysomes. Only after TCA-protein precipitation and western blot 
analysis, AGO1 shows strong signals particularly in the 80S and polysome fractions 
of the gradient (figure 6.13.C fractions # 7-19). Precipitated HPat peaks in the RNPs/ 
80S fractions (figure 6.13.I fraction # 4,5, 7,8) but is detected also in the polysomal 
fractions (figure 6.13.I fraction # 15, 16, 18) of the gradient. In TCA-precipitated 
fractions GW182 is detected predominantly in the RNP/80S fractions and much 
weaker than AGO1 or HPat in the polysomal fractions (figure 6.13.F fraction # 4-15) 
of the gradient. 
These results indicate that the decapping activator HPat and the crucial miRISC 
component AGO1 are co-migrating with the polysomes in sucrose density gradients 
while GW182 migrates mostly in the RNP/80S fractions. The experiments were 
repeated twice with similar results. 
 
6.3.2 Several factors involved in miRNA mediated silencing co-pellet with 
ribosomes 
 
In the following experiments I analyzed the co-migration of additional mRNA 
degradation factors (e.g. DCP1, Me31B, CCR4) with the ribosomes. Since polysome 
analysis requires the establishment of stable cell lines, I used an alternative method 
termed ribosome pelleting. First, I confirmed the results from the polysome analysis 
by testing AGO1, GW182 and HPat in ribosome pelleting experiments. Second, I 
analyzed tagged Me31B, DCP1 anc CCR4 in similar experiments. Therefore, c-myc-
tagged proteins of interest were transiently expressed in Drosophila S2 cells. After 3 
days, lysates were made and pelleted through a 1.5 M sucrose cushion. The pellet 
consists of high molecular weight complexes present e.g. monosomes and 
polysomes. The pellet and the input samples were separated on SDS-PAGE gels 
and analyzed by western blot analysis using polyclonal anti-c-myc antibody. This 
method provides an easy and fast way of testing any protein of interest for co-
sedimentation with the ribosomes. Besides, the cell amounts needed are quite low 
compared to polysome analysis.  
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Figure 6.14.: c-Myc-tagged HPat, Me31B, AGO1, DCP1 co-pellet with ribosomes 
(A) Schematic representation of miRNA mediated repression and the proteins involved 
(B) S2 cells transiently expressing the protein of interest (indicated above) were lysed and 
centrifuged over a 1.5 M sucrose cushion. Inputs (IN) and pellets (PE) were separated on 7.5 
% SDS-PAGE gels and analyzed by western blotting. Inputs for GW182 and HPat are 4 % of 
total lysate; inputs for Me31b and AGO1 are 4.15 % of total lysate; inputs of CCR4 and 
DCP1 are 4.7 % of total lysate. 
 
The general decapping activators HPat, Me31B and DCP1 co-sediment with the 
polyribosomes (figure 6.14. B lanes 4, 6, 12). Furthermore, AGO1 is also detected in 
the pellet (figure 6.14. B lane 8). The co-pelleting of HPat and AGO1 with the 
(poly)ribosomes is consistent with the previous polysome analyses showing as well a 
co-migration of these proteins with the polysomes (figure 6.13.C and I). The 
deadenylase protein CCR4 pelleted only to a low extent (figure 6.14. B lane 10). 
GW182 does not co-pellet with the (poly)ribosomes (figure 6.14.B lane 2) in these 
experiments. Similarly, GW182 was detected only weakly in the polysomes of the 
previous gradient experiments (figure 6.13.F). 
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In sum, these data suggest that epitope-tagged AGO1, HPat, Me31B and DCP1 
sediment with the (poly)ribosomes while CCR4 and GW182 do not. The experiments 
were performed in triplicates for c-Myc-AGO1, c-Myc-GW182 and in duplicates for c-
Myc-HPat. 
The results for c-Myc-tagged Me31B, CCR4 and DCP1 are considered as preliminary 
data since they have not been repeated. 
 
6.3.3 Co-immunoprecipitation experiments of epitope-tagged 
AGO1/HPat with epitope-tagged ribosomal proteins RpL11 and RpL23A 
 
In the previous experiments I demonstrated the co-migration of the miRNA effector 
protein AGO1 and the decapping activator HPat with polysomes in a sucrose density 
gradient and in ribosome pelleting. Since both methods are based on size separation 
of high molecular weight complexes, an equally valid explanation could be that any 
complexes (e.g. P bodies) are isolated and co-migrate with the polyribosomes. Thus, 
I wanted to test whether there is an association of the tested proteins with the 
ribosome complex.  
In order to address this question, I performed co-immunoprecipitation analysis of 
epitope-tagged HPat and AGO1 with epitope-tagged ribosomal proteins and vice 
versa. Co-Immunoprecipitations (co-IPs) are widely used to analyze protein 
complexes and protein – protein interactions. The method allows purifying any 
epitope-tagged protein of interest by using beads cross-linked to an antibody which is 
binding the tag. I used sepharose beads coated with protein A and covalently cross-
linked to monoclonal anti-HA antibody (figure 6.15.) in the following experiments. The 
ribosomal proteins RpL11 and RpL23A were chosen for the experiments since they 
are predicted to be at the surface of the ribosome in cryomaps of yeast 80S 
complexes (Andersen, 2006; Spahn, 2004).  
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Figure 6.15.: Scheme for co-Immunopreciptitation 
Sepharose beads coated with Protein A and cross-linked with monoclonal anti-HA antibody. 
On the right, upon addition of the lysate the tagged protein bind to the beads with its 
associated protein factors. 
 
First, I analyzed the co-IP of ribosomal proteins (c-Myc-RpL23A or c-Myc-RpL11) 
with HA-HPat. Secondly, I tested whether c-Myc-HPat or c-Myc-AGO1 co-
immunoprecipitate with ribosomal proteins. The epitope-tagged proteins were 
transiently expressed in Drosophila S2 cells. After three days, the cells were 
harvested and lysed. Next, these lysates were incubated with HA-coupled beads, 
washed and eluted with protein sample buffer. Then the samples were separated on 
7.5 % or 12 % SDS-PAGE gels and analyzed by western blot analysis using 
monoclonal anti-HA antibody or polyclonal anti-c-Myc antibody (figure 6.16). 
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Figure 6.16.: Co-immunoprecipitation of epitope-tagged RpL11/ RpL23A with epitope-
tagged AGO1/HPat 
(A) HA-tagged HPat and c-Myc-tagged ribosomal proteins were transiently expressed in S2 
cells. Proteins were immunoprecipitated using monoclonal anti-HA-antibody. c-Myc-GST 
served as a stringency control. (B) HA-tagged ribosomal protein (RpL11) transiently 
expressed in S2 cells with c-Myc-HPat. Proteins were immunoprecipitated using monoclonal 
anti-HA-antibody. HA-GST served as a stringency control. (C) HA-tagged ribosomal protein 
(RpL11) transiently expressed in S2 cells with c-Myc-AGO1. Proteins were 
immunoprecipitated using monoclonal anti-HA-antibody. HA-GST served as negative control. 
Inputs (2.5%) and immunoprecipitates (36%) were analyzed by Western blot analysis using 
anti-HA or anti-c-Myc-antibody. 
 
The co-immunoprecipitation results of HA-HPat with c-Myc-tagged ribosomal proteins 
are depicted in figure 6.16.A. The initial inputs of HA-HPat (figure 6.16.A lane 1,2,3 
upper panel;), the tagged ribosomal proteins (figure 6.16.A lane 1 and 2 lower panel) 
and c-Myc-GST (figure 6.16.A lane 3 lower panel) from the cell lysates demonstrate 
that all proteins are expressed. The anti-HA-probing shows the immunoprecipitation 
(IP) of HA-HPat on the beads (figure 6.16.A lane 4;5,6;) indicating that the procedure 
was technically working. The anti-c-Myc probing demonstrates that the epitope-
tagged ribosomal proteins did not co-purify with HA-HPat on the beads (figure 6.16.A. 
lane 4;5,). The c-myc-tagged Gluthathion-S-Transferase (c-Myc-GST) served as a 
stringency control. As anticipated, c-Myc-GST did not co-purify with HPat indicating 
that there is no unspecific binding (figure 6.16.A lane 6). 
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The next experiment was performed similar as the previous one. Figure 6.16 B and C 
depict the co-immunoprecipitation results of epitope-tagged RpL11 with epitope-
tagged HPat and AGO1 with reversed tags. As demonstrated by the input samples, 
all proteins (HA-RpL11, c-Myc-HPat, c-Myc-AGO1) were expressed in S2 cells 
(figure 6.16. B/C lane 1,2). The anti-HA probing indicates that the ribosomal protein 
HA-RpL11 was successfully immunopurified (figure 6.16. B/C lane 3). The anti-c-Myc 
probing demonstrates that neither c-Myc-HPat nor c-Myc-AGO1 co-purified with HA-
RpL11 (figure 6.16. B/C lane 3,4). Again, HA-GST was immunopurified (figure 6.16. 
B/C lane 4) and used as stringency control. Neither tagged AGO1 nor HPat co-purify 
with GST indicating that there is no unspecific association. 
In sum the co-immunoprecipitation experiments could not provide any evidence for 
association of HPat/AGO1 with the ribosomes, but also do not exclude an 
association.  
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7. Discussion 
This study aimed to identify novel miRNA targets repressed at the translational level 
by polysome analysis. Additionally, several proteins involved in miRNA-mediated 
repression and mRNA degradation were analyzed by polysome analysis, ribosome 
pelleting and co-immunprecipitation experiments. 
 
7.1. Putative endogenous miRNA targets in polysome analysis 
In this thesis, the putative endogenous miRNA targets analyzed in a polysome 
gradient from Drosophila S2 cells were hid and vha68-1. Both have been shown to 
undergo miRNA-mediated repression in Drosophila melanogaster. hid is an 
apoptosis-inducing gene whose mRNA is also detected in genes that do not undergo 
apoptosis (Grether 1995). It was found that the miRNA bantam regulates the hid 
mRNA in Drosophila melanogaster and thereby inhibits the hid-induced apoptosis 
(Brennecke, 2003). bantam promotes cell proliferation and is predicted to regulate up 
to 70 genes in D.melanogaster (Brennecke, 2003; Nahvi, 2009). It was demonstrated 
that upon bantam repression, the protein levels of hid were reduced while its mRNA 
levels remained constant (Brennecke, 2003).  
In this thesis, the hid mRNA was found to migrate with polysomes in a sucrose 
density gradient in Drosophila S2 cells. In the same polysome gradient, I detected 
bantam equally distributed in polysomal fractions and RNP-fractions. That suggests 
an association of the putative repressed hid mRNA with actively translating 
ribosomes. In my experiments, the repression of hid was not tested at the protein 
level. Consequently, it is possible that the gene is not repressed in Drosophila S2 
cells. This argument is weakend though by a report demonstrating that in Drosophila 
S2 cells a reporter harbouring the 3‟UTR of hid is repressed by bantam (Nahvi, 
2009). In addition, the levels of bantam during the embryonic stages of D. 
melanogaster are quite high (Behm-Ansmant, 2006) suggesting that in an embryonic 
cell line such as S2 cells, hid repression is expected. The distribution of bantam 
throughout the gradient is similar to previous studies in which miRNAs have been 
found to co-sediment with polysomes in human cells (Nottrott, 2006; Maroney, 2006). 
The endogenous miRNA target vha68-1 was identified as an mRNA repressed by 
miR9b in Drosophila (Rehwinkel, 2006). The gene was found to be regulated mainly 
on the mRNA level (Eulalio, 2007), thus upon repression mRNA is degraded. Behm-
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Ansmant and co-workers (Behm-Ansmant, 2006) reported that a Fluc-reporter fused 
to the 3‟UTR of vha68-1 was regulated similarly on mRNA and protein level in 
Drosophhila S2 cells.  
In this thesis, similarly to the hid mRNA, vha68-1 co-migrated with polysomes in a 
sucrose density gradient. Whether vha68-1 was indeed repressed in Drosophila S2 
cells was not confirmed. The fact that I never tested whether the putative miRNA 
targets, hid and vha68-1, are indeed repressed in the Drosophila S2 cells I used for 
the experiments makes an interpretation of the results difficult. Nevertheless, co-
migration of endogenous miRNA-targets with polysomes in a sucrose density 
gradient has been observed in other studies as well. Seggerson and co-workers 
(Seggerson, 2002) showed that in C.elegans the endogenous miRNA targets lin-14 
and lin-28 co-sediment with polysomes in a gradient. Endogenous miRNA targets 
were also found to co-migrate with polysomes in human cells (Nottrott, 2006; 
Maroney, 2006). 
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7.2. The Fluc-nerfin reporter in polysome analysis 
As an example for an ectopic miRNA target, a firefly-luciferase-nerfin (Fluc-nerfin) 
reporter was analyzed by polysome analysis (see section 6.2.2.). The reporter 
harbours binding sites for miR9b in its 3‟UTR. The Fluc-Nerfin reporter has been 
used in previous studies which demonstrated that miR9b inhibits its expression 
(Behm-Ansmant, 2006). Furthermore, it is known that upon miR9b repression, the net 
protein levels of the Fluc-nerfin decrease while mRNA levels remained almost 
unaffected (Behm-Ansmant, 2006). Thus, the reporter undergoes mainly translational 
regulation, rather than decay. In S2 cells, the nerfin-1 gene is not expressed and 
endogenous miR9b is only present at very low levels (Rehwinkel, 2006). 
In my experiments, the Fluc-Nerfin levels decreased significantly on protein level in 
the presence of miR9b. Thus, I demonstrated that Fluc-Nerfin undergoes a miR9b-
mediated repression. Nevertheless, in the polysome analysis the Fluc-nerfin mRNA 
was found to co-sediment with polyribosomes regardless from its repression state. 
Even if the reporter is highly repressed at the protein level, it co-migrates with actively 
translating ribosomes. 
In previously mentioned reports repressed reporter miRNA targets have been shown 
to co-sediment with polyribosomes in mammalian/human cells (Gu, 2009; Petersen, 
2006; Nottrott, 2006). Besides, an interesting study by Coller and co-workers (Hu, 
2009) demonstrated that deadenylation and decapping occurs already on actively 
translating ribosomes in yeast. Thus, miRNA targets could be degraded co-
translationally as well. Furthermore, it could be speculated that I separated 
polyribosomes and some different high molecular weight structures such as P bodies 
in polysome gradients. At least for P bodies this can be argued against, since it is 
known that P bodies disperse in the presence of cycloheximide (Sheth, 2003; 
Cougot, 2004; Teixeira, 2005) which I used to keep the polyribosomes intact during 
the experiments. 
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7.3. The ambiguous results from studies using polysome analysis 
There are several reports which observed a shift of mRNAs into the lighter (RNP) 
fractions of a polysome gradient upon miRNA-mediated repression. In most of these 
studies reporter miRNA targets were used in the experiments. Pillai and co-workers 
(Pillai, 2005) observed a shift of reporters repressed by endogous let-7 into the lighter 
gradient fractions. The shift was comparable to shifts caused by inhibitors of 
translational initiation. That led them to the conclusion that miRNAs interfere with 
translational initiation rather than with a step downstream of initiation in human cells. 
Similar shifts were observed in human lymphocytes using artificial reporters plus their 
cognate miRNA (Huang, 2007). To my knowledge, there are only two studies 
demonstrating shuttling of endogenous miRNA targets in a polysome gradient. One 
was performed by Bhattchyyra and co-workers (Bhattacharyya, 2006) in human Huh7 
cells. The analyzed mRNA was the CAT-1 mRNA which is targeted by miR-122. The 
report showed that upon deactivation of the miRNA by anti-miR-oligos, the mRNA 
shifts into heavy polysomal fractions. The second study was carried out in C.elegans 
by Ding and co-workers (Ding, 2009). The endogenous mRNA targets of the let-7 
(daf-12 and lin-41) and lin-4 miRNA (lin-14 and lin-28) were analyzed. Upon 
repression they observed shifts of several mRNA targets from the polysomal fractions 
into the RNP fractions of the gradient. These studies concluded as well that miRNA-
mediated inhibition occurs at the translational initiation step. Interestingly, the same 
C. elegans lin-4 miRNA targets have been studied already in polysome profiles in 
1999 by Olsen and co-workers (Olsen, 1999) with a different results. This report did 
not show shifts in a polysome profile upon repression and therefore that study fueled 
the post-initiation inhibition theory.  
The reasons for the contradictory findings concerning miRNA-mediated repression in 
polysome analysis remain unclear. Possibly, as proposed by several authors, there 
are more than one mechanism of miRNA silencing which might depend on the target 
mRNAs or on the microRNAs studied. However, also some other factors might play a 
role. For instance, an interesting report was published by Thermann and Hentze 
(Thermann, 2007). In the study, a cell-free system of D.melanogaster embryos was 
used to analyze reporter mRNAs targeted by the miRNA miR2. They inhibited the 
formation of polysomes and demonstrated that miR2 induces the formation of heavy 
mRNPs (pseudo-polysomes) which sediment similar to polysomes in a sucrose 
density gradient. Although this study was done in an in vitro system, it does not 
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exclude the possibilty that similar structures might also form in cells. Thus, the co-
migration of repressed mRNAs with polyribosomes in a gradient could also be due to 
other heavy mRNP structures.  
Furthermore, a study from Kong and co-workers (Kong, 2008) demonstrated that the 
promoters used to transcribe the mRNA reporters targeted by miRNAs can influence 
miRNA-mediated repression. The study compared transcripts with let-7 binding sites 
in their 3‟UTR derived from a SV40 and a TK promoter in HeLa cells. The SV40 
transcripts migrated predominantly in RNP fractions while the TK transcripts migrated 
throughout the gradient. Another report (Lytle, 2007) demonstrated that the 
transfection method can affect the miRNA mediated repression in HeLa cells. In the 
study, electroporation and lipid-mediated transfections of DNA and RNA were 
compared and the differences concerning miRNA-mediated repression were 
significant. The authors state that the differences rely mostly on the amount of DNA 
which is taken up by the cell and that a high amounts of DNA saturate the ability of 
the miRNA system to repress translation.  
It is of interest that the differences in the experimental procedure can have an effect 
the outcome. 
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7.4. Perspectives of identification of novel miRNA targets by polysome 
analysis  
In my polysome analyses neither reporter nor endognous miRNA targets shifted in 
the gradient and remained co-migrating with polysomes even though there was a 
significant repression at the protein level. To my knowledge, there was only one 
report (Nakamoto, 2005) which found miRNA targets by using a combined approach 
of polysome analysis and microarray/real-time PCR analysis (see section 3.7.2). The 
study was carried out in human cells and a reporter mRNA target targeted by miR-
30a-3p was assayed in a polysome profile. Upon a knockdown of the miRNA they 
observed a significant shift of the reporter into the heavy polysomal fractions. By 
assuming that endogenous mRNA targets of this miRNA behave the same, 8 novel 
mRNAs targeted by miR-30a-3p were identified and validated.  
Thus, polysome analysis is applicable for miRNA target identification. Nevertheless, 
the lack of explanations for the controverse data on the behaviour of miRNA targets 
in a polysome profile makes the approach less favourable.  
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7.5. Studying important factors involved in miRNA-mediated silencing 
The co-migration of repressed miRNA targets with polysomes in my sucrose density 
gradients led to the questions about the migration of the proteins involved in miRNA-
mediated silencing in a gradient. Of particular interest were the key players of the 
miRISC, AGO1 and GW182. The decapping activator HPat has been found recently 
by our lab to co-purify with GW182, and therefore we decided to study the migration 
of this protein as well. At that point an interesting report (Hu, 2009) was published 
demonstrating that the decapping of mRNAs happens at least to some extent on 
polyribosomes in yeast. Thus, we speculated that miRNA-mediated decay could also 
take place on actively translating ribosomes. 
My experiments demonstrated that TAP-tagged AGO1 and HPat proteins co-migrate 
with the heavy polysomes in the sucrose density gradient. This is consistent with 
literature for instance with a report which found AGO proteins co-migrating with 
polysomes in HeLa cells (Nottrott, 2006). Furthermore, the homolog of HPat in yeast 
(Pat1p) has also been detected in the polysomal fractions of a gradient in other 
studies (Bonnerot, 2000; Wyers, 2000). In addition I analyzed TAP-GW182 in a 
polysome gradient and found a very weak co-migration with polysomes compared to 
TAP-tagged AGO1 or HPat. To my knowledge, there are no studies analyzing the 
migration of GW182 in polysome gradients. 
In order to test several other factors of the mRNA degradation machinery, I 
performed ribosome pelleting experiments. I found that tagged AGO1, HPat, DCP1, 
Me31B co-pellet with ribosomes while GW182 and CCR4 do not. In sum, these 
findings let me speculate about possible direct association of factors involved in 
miRNA-mediated decay and/or the general decay machinery to the ribosomes. 
However, since the co-migration/co-pelleting of proteins with ribosomes is based on 
fractionation by size, any high molecular weight complexes can be separated by 
these methods. 
Nevertheless, I tried to detect an association of HPat or AGO1 to the ribosomes in 
co-immunoprecipitation experiments. I was not able to get positve results from these 
experiments. One critic point is, that the ribosomal proteins I used for the 
experiments were not further examined in detail. I neither demonstrated that the 
proteins are actually incorporated into a functional ribosome nor did I proof that I 
actually pulled down ribosomes in the experiments.  
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